Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Large accelerated filer

Accelerated filer

Non-accelerated
filer

Smaller reporting company

Emerging growth company

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended

June 30, 2024

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission File Number

001-41161

Investcorp Europe Acquisition Corp I

(Exact name of registrant as specified in its charter)


Cayman Islands		N/A
(State or other jurisdiction of incorporation)		(IRS Employer Identification No.)

Century Yard, Cricket Square Elgin Avenue P.O. Box 1111, George Town Grand Cayman, Cayman Islands		KY1-1102
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: +1 (

345

)

949-5122

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant	IVCBU	The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share	IVCB	The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50	IVCBW	The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES

☒ NO ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).

YES

☒ NO ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, a smaller reporting company, or an emerging growth company. See the definition of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule

12b-2

of the Exchange Act.:

If an emerging growth company, indicate by the check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). YES ☒ NO ☐

As of August 16, 2024, there were 18,010,684 Class A ordinary shares, $0.0001 par value, and 1 Class B ordinary share, $0.0001 par value, issued and outstanding.

INVESTCORP EUROPE ACQUISITION CORP I

INDEX TO FINANCIAL STATEMENTS


	Page
PART I FINANCIAL INFORMATION

Item 1. Financial Statements
Condensed Balance Sheets as of June 30, 2024 (unaudited) and December 31, 2023 (as revised)		1
Condensed Statements of Operations for the three and six months ended June 30, 2024 (unaudited) and the three and six months ended June 30, 2023 (unaudited)		2
Condensed Statements of Changes in Shareholders’ Deficit for the three and six months ended June 30, 2024 (unaudited) and the three and six months ended June 30, 2023 (unaudited)		3
Condensed Statements of Cash Flows for the six months ended June 30, 2024 (unaudited) and the six months ended June 30, 2023 (unaudited)		5
Notes to Condensed Financial Statements (unaudited)		6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		29
Item 3. Quantitative and Qualitative Disclosures About Market Risk		35
Item 4. Controls and Procedures		36

PART II OTHER INFORMATION

Item 1. Legal Proceedings		37
Item 1A. Risk Factors		37
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		37
Item 3. Defaults Upon Senior Securities		37
Item 4. Mine Safety Disclosures		37
Item 5. Other Information		37
Item 6. Exhibits		38
Signatures		39

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

INVESTCORP EUROPE ACQUISITION CORP I

CONDENSED BALANCE SHEETS


	As of June 30, 2024 (Unaudited)			As of December 31, 2023 (As revised)
Assets
Current Assets
Cash	$	182,038		$	98,676
Prepaid expenses		68,572			76,239
Interest receivable		—			62,706

Total Current Assets		250,610			237,621
Cash held in Trust Account		106,759,103			127,703,238

Total Assets	$	107,009,713		$	127,940,859

Liabilities, Shares Subject to Redemption and Shareholders’ Deficit
Current Liabilities
Accounts payable and accrued expenses	$	4,225,970		$	8,650,534
Note Payable to Sponsor		6,450,000			4,750,000
Note Payable to Target		7,899,180			—

Total Current Liabilities		18,575,150			13,400,534
Warrant liabilities		2,462,000			7,782,000
Deferred underwriting fee payable		6,037,500			12,075,000

Total Liabilities	$	27,074,650		$	33,257,534

Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 9,385,685 and 11,545,295 shares at $11.37 and $11.07 per share redemption value at June 30, 2024 and December 31, 2023, respectively		106,759,103			127,765,944
Shareholders’ Deficit
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at June 30, 2024 and December 31, 2023		—			—
Class A ordinary shares, $0.0001 par value, 400,000,000 shares authorized, 8,624,999 issued and outstanding at June 30, 2024 and December 31, 2023 (excluding 9,385,685 and 11,545,295 shares subject to possible redemption, respectively)		863			863
Class B ordinary shares, $0.0001 par value, 40,000,000 shares authorized, 1 issued and outstanding shares at June 30, 2024 and December 31, 2023		—			—
Accumulated deficit		(26,824,903	)		(33,083,482	)

Total Shareholders’ Deficit		(26,824,040	)		(33,082,619	)

Total Liabilities, Shares Subject to Redemption and Shareholders’ Deficit	$	107,009,713		$	127,940,859

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

INVESTCORP EUROPE ACQUISITION CORP I

CONDENSED UNAUDITED STATEMENTS OF OPERATIONS


	For the three months ended						For the six months ended
	June 30, 2024			June 30, 2023			June 30, 2024			June 30, 2023
Formation and operating costs	$	3,355,845		$	2,885,101		$	6,796,667		$	6,595,415

Loss from Operations		(3,355,845	)		(2,885,101	)		(6,796,667	)		(6,595,415	)
Other income (expense)
Change in fair value of warrant liabilities		(1,273,750	)		(3,249,935	)		5,320,000			(5,264,750	)
Interest earned on Cash and Investments held in Trust Account		1,282,016			2,382,313			2,685,613			5,991,131
Forgiveness of legal fees		2,546,926			—			2,546,926			—
Interest expense		(99,180	)		—			(99,180	)		—

Total other income (expense)		2,456,012			(867,622	)		10,453,359			726,381

Net Income (Loss)	$	(899,833	)	$	(3,752,723	)	$	3,656,692		$	(5,869,034	)

Basic and diluted weighted average redeemable Class A ordinary shares outstanding		10,572,284			19,005,667			11,058,789			24,826,742

Basic and diluted net income (loss) per redeemable Class A ordinary share	$	(0.05	)	$	(0.14	)	$	0.19		$	(0.18	)

Basic and diluted weighted average non-redeemable ordinary shares outstanding		8,625,000			8,625,000			8,625,000			8,625,000

Basic and diluted net income (loss) per non-redeemable ordinary share	$	(0.05	)	$	(0.14	)	$	0.19		$	(0.18	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

INVESTCORP EUROPE ACQUISITION CORP I

CONDENSED UNAUDITED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2024


	Ordinary Shares				Ordinary Shares							Total
	Class A				Class B				Accumulated			Stockholders’
	Shares		Amount		Shares		Amount		Deficit			Deficit
Balance – December 31, 2023 (as revised)		8,624,999	$	863		1	$	—	$	(33,083,482	)	$	(33,082,619	)
Extension Contribution		—		—		—		—		(450,000	)		(450,000	)
Remeasurement of redeemable shares to redemption value		—		—		—		—		(1,403,597	)		(1,403,597	)
Net income		—		—		—		—		4,556,525			4,556,525

Balance – March 31, 2024 (unaudited)		8,624,999	$	863		1	$	—	$	(30,380,554	)	$	(30,379,691	)
Deferred underwriters’ fee commission waiver		—		—		—		—		6,037,500			6,037,500
Extension Contribution		—		—		—		—		(300,000	)		(300,000	)
Remeasurement of redeemable shares to redemption value		—		—		—		—		(1,282,016	)		(1,282,016	)
Net loss		—		—		—		—		(899,833	)		(899,833	)

Balance – June 30, 2024 (unaudited)		8,624,999	$	863		1	$	—	$	(26,824,903	)	$	(26,824,040	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

INVESTCORP EUROPE ACQUISITION CORP I

CONDENSED UNAUDITED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023


	Ordinary Shares Class B				Additional Paid-in		Accumulated			Total Stockholders’
	Shares		Amount		Capital		Deficit			Deficit
Balance – December 31, 2022 (audited)		8,625,000	$	863	$	—	$	(13,843,693	)	$	(13,842,830	)
Extension contribution		—		—		—		(350,000	)		(350,000	)
Remeasurement of redeemable shares to redemption value		—		—		—		(3,608,818	)		(3,608,818	)
Net loss		—		—		—		(2,116,311	)		(2,116,311	)

Balance – March 31, 2023 (unaudited)		8,625,000	$	863	$	—	$	(19,918,822	)	$	(19,917,959	)
Extension contribution		—		—		—		(1,050,000	)		(1,050,000	)
Remeasurement of redeemable shares to redemption value		—		—		—		(2,382,313	)		(2,382,313	)
Net loss		—		—		—		(3,752,723	)		(3,752,723	)

Balance – June 30, 2023 (unaudited)		8,625,000	$	863		—	$	(27,103,858	)	$	(27,102,995	)

The accompanying notes are an integral part of these condensed unaudited financial statements.

Table of Contents

INVESTCORP EUROPE ACQUISITION CORP I

CONDENSED UNAUDITED STATEMENTS OF CASH FLOWS


	For the six months ended
	June 30, 2024			June 30, 2023
Cash Flows from Operating Activities:
Net income (loss)	$	3,656,692		$	(5,869,034	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on Cash and Investments held in Trust Account		(2,685,613	)		(5,991,131	)
Forgiveness of legal fees		(2,546,926	)		—
Change in fair value of warrant liabilities		(5,320,000	)		5,264,750
Changes in operating assets and liabilities:
Prepaid expenses		7,667			317,519
Accounts payable and accrued expenses		(1,877,638	)		5,433,121

Net cash used in operating activities		(8,765,818	)		(844,775	)
Cash Flows from Investing Activities:
Extension Contribution		(750,000	)		(1,400,000	)
Withdrawal from Trust Account for Redemptions		24,442,454			—

Net cash provided by (used in) investing activities		23,692,454			(1,400,000	)
Cash Flows from Financing Activities:
Proceeds from affiliate promissory note		1,700,000			2,000,000
Proceeds from target promissory note		7,899,180			—
Redemptions paid out		(24,442,454	)		—

Net cash (used in) provided by financing activities		(14,843,274	)		2,000,000

Net change in cash		83,362			(244,775	)
Cash at beginning of period		98,676			479,009

Cash at end of period	$	182,038		$	234,234

Supplemental disclosure of cash flow information:

Remeasurement of redeemable shares to redemption value	$	2,685,613		$	5,991,131
Deferred underwriters’ fee commission waiver	$	6,037,500		$	—

The accompanying notes are an integral part of these condensed unaudited financial statements.

Table of Contents

INVESTCORP EUROPE ACQUISITION CORP I

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Note 1—Organization and Business Operation

Investcorp Asia Acquisition Corp I was incorporated in the Cayman Islands on

March 22, 2021

. On October 7, 2021, the Company changed its name to Investcorp Europe Acquisition Corp I (the “Company”). The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or assets (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of June 30, 2024, the Company had not commenced any operations. All activity for the period from March 22, 2021 (inception) through June 30, 2024 relates to the Company’s formation and Initial Public Offering of units (the “IPO”) described below, and since the IPO, the search for a target business. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company expects to generate

non-operating

income in the form of interest income on cash and cash equivalents from the proceeds expected to be derived from the IPO. The Company has selected December 31 as its fiscal year end.

The registration statement for the Company’s IPO was declared effective on December 14, 2021 (the “Effective Date”). On December 17, 2021, the Company consummated its IPO of 34,500,000 units, which included the full exercise of the underwriters’ over-allotment option of 4,500,000 units (the “Units” and, with respect to the ordinary shares included in the Units offered, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $345,000,000, which is discussed further in Note 3.

Simultaneously with the closing of the IPO, the Company consummated the sale of 16,700,000 warrants (the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant in a private placement to Europe Acquisition Holdings Limited (the “Sponsor”), generating proceeds of $16,700,000.

Following the closing of the IPO on December 17, 2021, $351,900,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account (“Trust Account”), located in the United States at a nationally recognized financial institution, with Continental Stock Transfer & Trust Company (“Continental”) acting as trustee. Prior to December 14, 2023, funds in the Trust Account were held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule

2a-7

under the Investment Company Act of 1940 (the “Investment Company Act”). However, to mitigate the risk of the Company being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), prior to the

24-month

anniversary of the Effective Date of the registration statement relating to the Company’s IPO, the Company instructed Continental to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and to hold all funds in the Trust Account in cash in an interest bearing account until the earlier of consummation of its initial Business Combination or liquidation. In connection with such instructions, on December 14, 2023, the Company and Continental entered into an amendment to the Investment Management Trust Agreement dated December 11, 2021 (the “Trust Agreement”), which governs the investment of monies held in the Trust Account, to specifically allow the investment of those funds into an interest-bearing account.

Pursuant to the Trust Agreement, the trustee is not permitted to invest in other securities or assets. The Trust Account is intended as a holding place for funds pending the earliest to occur of either: (i) the completion of the initial Business Combination; (ii) the redemption of any Public Shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (the “Articles”) to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within the time frame to consummate the business combination period (the “Business Combination Period”) as defined in its Articles or during any extended time that the Company has to consummate a Business Combination as a result of a shareholder vote to amend its Articles (an “Extension Period”) or (B) with respect to any other provision relating to shareholders’ rights or

pre-Business

Combination activity; and (iii) absent an initial Business Combination within the Business Combination Period or Extension Period from the closing of the IPO, the return of the funds held in the Trust Account to the Company’s public shareholders as part of the redemption of the Public Shares.

Table of Contents

If the Company has not consummated the initial Business Combination within the required time period, the public shareholders may receive only approximately $10.20 per Public Share, or less in certain circumstances, on the liquidation of the Trust Account and the warrants will expire worthless.

If the Company seeks shareholder approval to proceed with a Business Combination, a majority of the shares voted in favor of the Business Combination would be required. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Articles, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the IPO in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or don’t vote at all.

Notwithstanding the above, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Articles provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Extension Period and (c) not to propose an amendment to the Articles (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to shareholders’ rights or

pre-initial

business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Extension Period. However, if the Sponsor acquires Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Extension Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 11) held in the Trust Account in the event the Company does not complete a Business Combination within the Extension Period; and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than $10.20 per Public Share.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.20 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.20 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Extraordinary General Meetings

On March 14, 2023, the Company convened an extraordinary general meeting (the “First Extraordinary General Meeting”) virtually, to vote on the proposals described below. A total of 34,372,929 of the Company’s Class A ordinary shares and Class B ordinary shares (the “Ordinary Shares”), or 79.1% of the Company’s outstanding shares as of February 22, 2023, the record date for the First Extraordinary General Meeting, were represented virtually or by proxy at the First Extraordinary General Meeting.

As approved by its shareholders at the First Extraordinary Meeting, the Company filed an amendment (the “First Extension Amendment”), which (i) extended the date by which the Company must consummate its initial Business Combination from March 17, 2023 to December 17, 2023 and (ii) removed the limitation that the Company shall not redeem public shares to the extent that such redemption would cause the Company’s net tangible assets to be less than $5,000,001 (the “Redemption Limitation Amendment”).

Table of Contents

Additionally, at the First Extraordinary General Meeting holders of Public Shares were afforded the opportunity to require the Company to redeem their Public Shares for their pro rata share of the Trust Account. In connection with the vote to approve the First Extension Amendment and the Redemption Limitation Amendment, the holders of 15,494,333 Class A ordinary shares properly exercised their rights to redeem their shares for cash at a redemption price of approximately $10.43 per share for an aggregate redemption amount of approximately $161.6 million, leaving 19,005,667 Public Shares remaining outstanding. Following this redemption, the balance in the Trust Account was approximately $198.2 million.

In connection with the approval of the First Extension Amendment, the Sponsor had agreed, by making monthly advancements on the March 2023 Loan (as defined below), to contribute (each such contribution, an “Extension Contribution”) into the Trust Account the lesser of (x) an aggregate of $350,000 or (y) $0.03 per share for each public share that was not redeemed at the First Extraordinary General Meeting for each monthly period (commencing on March 17, 2023 and ending on the 17

day of each subsequent month), or prior thereof, until the earlier of the completion of the initial Business Combination and December 17, 2023.

On December 5, 2023, the Company held an extraordinary general meeting (the “Second Extraordinary General Meeting”), at which holders of Public Shares approved an amendment to the Articles to extend the date by which the Company must complete its initial Business Combination from December 17, 2023 to June 17, 2024. As a result of the approval of the extension to June 17, 2024, the Sponsor agreed, by making monthly advancements on the Loans (as defined below), to make Extension Contributions into the Trust Account in the amount of the lesser of (x) an aggregate of $150,000 or (y) $0.02 per share for each Class A ordinary share included as part of the Units sold in the Company’s IPO (including any shares issued in exchange thereof) that were not redeemed at the Second Extraordinary General Meeting for each monthly period (commencing on December 17, 2023 and ending on the 17th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial Business Combination and June 17, 2024.

Additionally, at the Second Extraordinary General Meeting holders of Public Shares were afforded the opportunity to require the Company to redeem their Public Shares for their pro rata share of the Trust Account. The holders of 7,460,372 Class A ordinary shares properly exercised their rights to redeem their shares for cash at a redemption price of approximately $11.00 per share for an aggregate redemption amount of approximately $82.0 million, leaving 11,545,295 Public Shares remaining outstanding.

On May 21, 2024, the Company held an extraordinary general meeting (the “Third Extraordinary General Meeting”) to vote on a proposal to approve an Amendment to the Company’s Articles extending the date by which the Company must complete its initial Business Combination from June 17, 2024 to December 17, 2024 (the “Third Extension Amendment Proposal” and with respect to December 17, 2024, the “Extended Date”), and the stockholders approved the Third Extension Amendment Proposal at that meeting. In connection with the vote to approve the Third Extension Amendment Proposal, the holders of 2,159,610 Class A ordinary shares properly exercised their rights to redeem their shares for cash at a redemption price of $11.32 per share. In connection with this redemption, approximately $24.4 million was withdrawn from the Trust Account to fund such redemptions.

As of June 30, 2024, the Company had made nine Extension Contribution payments pursuant to the March 2023 Loan, the July 2023 Loan and the November 2023 Loan (as defined below), each in the amount of $350,000, as well as six Extension Contribution Payments pursuant to the Second November 2023 Loan and the April 2024 Loan, each in the amount of $150,000. For a more detailed description of the Loans, see “Liquidity, Capital Resources and Going Concern.” In connection with the Third Extension, the Company ceased making Extension Contributions on June 17, 2024.

Liquidity, Capital Resources and Going Concern

As of June 30, 2024, the Company had $182,038 in its operating bank accounts and working capital deficit of $18,324,540. As of June 30, 2024, approximately $6,975,116 of the amount on deposit in cash held in the Trust Account represented interest income and $4,050,000 represented an Extension Contribution, all of which are available to pay the Company’s tax obligations, if any.

The Company’s liquidity needs up to December 17, 2021 had been satisfied through a payment from the Sponsor of $25,000 (see Note 6) for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of up to $300,000. In addition, in order to finance transaction costs in connection with the Business Combination, the Company’s Sponsor, an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 6). As of June 30, 2024, there were no amounts outstanding under any Working Capital Loans.

Table of Contents

On March 7, 2023, the Company entered into a

non-interest

bearing convertible unsecured loan (the “March 2023 Loan”) in the principal amount of up to $2,000,000 from one of the Sponsor’s affiliates to provide the Company with additional working capital and to fund the Extension Contributions. The portion of the March 2023 Loan used to provide the Company with additional working capital was not deposited into the Trust Account. If the Company does not consummate an initial Business Combination by the Extension Period, the March 2023 Loan will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The March 2023 Loan is convertible into Private Placement Warrants of the post-Business Combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. The conversion option represents an embedded derivative under ASC

815-15,

“Embedded Derivatives.” The Company has determined that based on the valuation of its Private Placement Warrants and the fact that a Business Combination is not considered probable until such time as it is consummated, the value of this conversion option is de minimis.

In addition, on July 6, 2023, November 15, 2023, November 27, 2023, April 15, 2024 and June 6, 2024, the Company entered into

non-interest

bearing unsecured loans in the principal amount of up to $1,700,000 (the “July 2023 Loan”), in the principal amount of up to $500,000 (the “November 2023 Loan”), in the principal amount of up to $1,250,000 (the “Second November 2023 Loan”), in the principal amount of up to $750,000 (the “April 2024 Loan”), and in the principal amount of up to $1,200,000 (the “June 2024 Loan” and, together with the March 2023 Loan, the July 2023 Loan, the November 2023 Loan, the Second November 2023 Loan and the April 2024 Loan, the “Loans”) with an affiliate of the Sponsor to provide the Company with additional working capital and to fund Extension Contributions into the Trust Account until the earlier of a completion of the Business Combination or the Extended Date. The July 2023 Loan, the November 2023 Loan, the Second November 2023 Loan, the April 2024 Loan and the June 2024 Loan bear no interest and shall be due and payable on the earlier of (i) the date on which the Company consummates a Business Combination or (ii) the date of that the winding up of the Company is effective. If the Company does not consummate an initial Business Combination by the Extended Date, the July 2023 Loan, the November 2023 Loan, the Second November 2023 Loan, the April 2024 Loan and the June 2024 Loan will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. If at any time the board of directors of the Company determines that the Company will not be able to consummate an initial Business Combination by the Extended Date and that the Company shall instead liquidate, the Sponsor’s obligation to continue to make the Extension Contributions shall cease immediately upon such determination.

The total amount outstanding under the Loans entered into on March 7, 2023, July 6, 2023, November 15, 2023, November 27, 2023, April 15, 2024, June 6, 2024 and any other Working Capital Loans as of June 30, 2024 and December 31, 2023 was $6,450,000 and $4,750,000, respectively.

If the Company is not able to consummate a Business Combination before the end of the Extension Period, the Company will commence an automatic winding up, dissolution and liquidation. Management has determined that automatic liquidation, should a Business Combination not occur, and potential subsequent dissolution also raises substantial doubt about the Company’s ability to continue as a going concern. While management intends to complete a Business Combination, it is uncertain whether the Company will be able to do so. No adjustments have been made to the carrying amounts of assets or liabilities.

Under Accounting Standards Update (ASU)

2014-15,

“Presentation of Financial Statements—Going Concern (Subtopic

205-40):

Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU

2014-15”),

these conditions, including the working capital deficit as well as the remaining time in the Extension Period, raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. There is no assurance that the Company’s plan to consummate a Business Combination will be successful within the Extension Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 2—Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form

10-Q

and Article 8 of Regulation

S-X

of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form

10-K

for the year ended December 31, 2023, as filed with the SEC on April 11, 2024, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2023, is derived from the audited financial statements presented in the Company’s Annual Report on Form

10-

K for the year ended December 31, 2023, as filed with the SEC on April 11, 2024.

Table of Contents

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of these financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments, which include short-term bank deposits that are not restricted as to withdrawal or use, and short-term debentures, with original periods to maturity not exceeding three months, to be cash equivalents. The Company had cash of $182,038 and $98,676 as of June 30, 2024 and December 31, 2023, respectively. The Company had no cash equivalents as of June 30, 2024 and December 31, 2023.

Cash Held in Trust Account

Investments in money market funds are recognized at fair value and are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from cash held in the Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of June 30, 2024 and December 31, 2023, the assets held in the Trust Account consisted of cash in the amount of $106,759,103 and $127,703,238, respectively.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of June 30, 2024, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Table of Contents

Offering Costs Associated with Initial Public Offering

The Company complies with the requirements of the ASC

340-10-S99-1

and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs are charged to shareholders’ equity or the statement of operations based on the relative value of the Units that consist of one Class A ordinary share and

one-half

of one redeemable warrant (“Public Warrants”) and the Private Placement Warrants to the proceeds received from the Units sold upon the completion of the IPO. Accordingly, on December 17, 2021 offering costs totaling $20,078,227 (consisting of $6,900,000 of underwriting fee, $12,075,000 of deferred underwriting fee and $1,103,227 of other offering costs) were recognized with $854,057 included in accumulated deficit as an allocation for the Public Warrants and the Private Placement Warrants. Subsequent to the IPO, upon invoice receipt, other offering costs were adjusted downwards by $94,443 to true up estimates to the actual expenses incurred.

Net Income (Loss) Per Ordinary Share

The Company’s statements of operations include a presentation of net income (loss) per share for Ordinary Shares subject to possible redemption and applies the

two-class

method in calculating net income (loss) per share. Net income (loss) per Ordinary Share, basic and diluted, is calculated by dividing the

pro-

rata allocation of net income (loss) for each class, by the weighted average number of Class A and Class B

non-redeemable

Ordinary Shares outstanding for the period. Net income (loss) is allocated

pro-rata

between Class A redeemable and Class B

non-redeemable

shares based on their respective weighted average shares outstanding for the period. As of June 30, 2024, the potential Ordinary Shares for outstanding Public and Private Warrants to purchase the Company’s Ordinary Shares were excluded from diluted earnings per share for the three and six months ended June 30, 2024 because they are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per Ordinary Share is the same as basic net income per Ordinary Share for the period.

The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):


	For the three months ended
	June 30, 2024						June 30, 2023
	Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares			Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares
Basic and diluted net loss per share:
Numerator:
Allocation of net loss	$	(495,554	)	$	(404,279	)	$	(2,581,299	)	$	(1,171,424	)

Denominator:
Weighted-average shares outstanding		10,572,284			8,625,000			19,005,667			8,625,000

Basic and diluted net loss per share	$	(0.05	)	$	(0.05	)	$	(0.14	)	$	(0.14	)


	For the six months ended
	June 30, 2024				June 30, 2023
	Redeemable Class A Ordinary Shares		Non- Redeemable Ordinary Shares		Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares
Basic and diluted net (loss) income per share:
Numerator:
Allocation of net (loss) income	$	2,054,411	$	1,602,281	$	(4,355,797	)	$	(1,513,237	)

Denominator:
Weighted-average shares outstanding		11,058,789		8,625,000		24,826,742			8,625,000

Basic and diluted net (loss) income per share	$	0.19	$	0.19	$	(0.18	)	$	(0.18	)

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Table of Contents

Fair Value Measurements

The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.

Level 1—Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.

Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is

then re-valued at

each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current

or non-current based

on whether or

not net-cash settlement

or conversion of the instrument could be required within 12 months of the balance sheet date.

The 33,950,000 warrants issued in connection with the IPO and the Private Placement (including the 17,250,000 Public Warrants included in the Units and the 16,700,000 Private Placement Warrants) were recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject

to re-measurement at

each balance sheet date until exercised. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified

as non-current liabilities

as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable Ordinary Shares (including Ordinary Shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events.

Accordingly, as of June 30, 2024 and December 31, 2023, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet.

Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount. Increases or decreases in the carrying amount of redeemable Ordinary Shares are affected by charges against

additional paid-in capital

and accumulated deficit.

Table of Contents

As of June 30, 2024 and December 31, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:


	June 30, 2024			December 31, 2023
As of beginning of the period	$	127,765,944		$	356,976,644
Less:
Redemptions as a result of Extraordinary General Meeting		(24,442,454	)		(243,649,972	)
Plus:
Extension Contribution		750,000			3,300,000
Remeasurement of carrying value to redemption value		2,685,613			11,139,272

Class A ordinary shares subject to possible redemption	$	106,759,103		$	127,765,944

Income taxes

The Company accounts for income taxes in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under the asset and liability, method as required by this accounting standard, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities in the financial statements and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to the period when assets are realized or liabilities are settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statement of operations in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

There were no unrecognized tax benefits as of June 30, 2024. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2024, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties.

There is currently no taxation imposed by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU

No. 2020-06,

“Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU

2020-06”).

The update simplifies the accounting for convertible instruments by removing certain separation models in Subtopic

470-20,

Debt—Debt with Conversion and Other Options for convertible instruments and introducing other changes. As a result of ASU

No. 2020-06,

more convertible debt instruments will be accounted for as a single liability measured at amortized cost and more convertible preference shares will be accounted for as a single equity instrument measured at historical cost, as long as no features require bifurcation and recognition as derivatives. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU

No. 2020-06

upon its inception. The impact to the balance sheet, statements of operations and cash flows was not material.

Table of Contents

In December 2023, the FASB issued ASU No

2023-09,

“Income Taxes (Topic 740)—Improvements to Income Tax Disclosures” (“ASU

2023-09”)

in order to enhance the transparency and usefulness of income tax disclosures. The guidance is applicable to all entities subject to income tax, and it will require disclosure of certain categories within the rate reconciliation to improve consistency as well as disclosure of reconciling items which meet a certain quantitative threshold which will improve transparency. Additionally, entities must disclose the amount of taxes paid to federal, state and foreign municipalities. For public business entities ASU

2023-09

is effective for annual periods beginning after December 15, 2024. The Company expects to adopt the standard for the fiscal year beginning December 31, 2024. The Company is currently evaluating the impact of its pending adoption of ASU

2023-09

on its financial position, results of operations or financial statement disclosure.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Note 3— Initial Public Offering

On December 17, 2021 the Company sold 34,500,000 Units, which included 4,500,000 Units from the underwriters’ full exercise of their over-allotment option, at a price of $10.00 per Unit, generating gross proceeds to the Company of $345,000,000. Each Unit consists of one Class A ordinary share and

one-half

of one redeemable warrant. Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 10).

Following the closing of the IPO on December 17, 2021 an aggregate of $351,900,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into the Trust Account. Prior to December 14, 2023, funds in the Trust Account were held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule

2a-7

under the Investment Company Act. However, to mitigate the risk of the Company being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), prior to the

24-month

anniversary of the Effective Date of the registration statement relating to the Company’s IPO, the Company instructed Continental to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and to hold all funds in the Trust Account in cash in an interest bearing account until the earlier of consummation of its initial Business Combination or liquidation. In connection with such instructions, on December 14, 2023, the Company and Continental entered into an amendment to the Trust Agreement to specifically allow the investment of those funds into an interest-bearing account.

Transaction costs of the IPO amounted to $20,078,227 consisting of $6,900,000 of underwriting fee, $12,075,000 of deferred underwriting fee and $1,103,227 of other offering costs. Of the transaction costs, $19,224,170 was included in additional

paid-in

capital and $854,057 was included in accumulated deficit.

Note 4— Signed Business Combination Agreement

Original Business Agreement

On April 25, 2023, the Company entered into a business combination agreement (the “Business Combination Agreement”) with Zacco Holdings (formerly OpSec Holdings), a Cayman Islands exempted company with limited liability (“Pubco”), Opal Merger Sub I, a Cayman Islands exempted company incorporated with limited liability and wholly- owned subsidiary of Pubco (“Merger Sub I”), Opal Merger Sub II, a Cayman Islands exempted company incorporated with limited liability and wholly- owned Subsidiary of Pubco (“Merger Sub II”), Orca Holdings Limited, a Cayman Islands exempted company incorporated with limited liability (“Orca”), Orca Midco Limited, a private limited company incorporated under the Laws of England and Wales (“Orca Midco”), Orca Bidco Limited, a private limited company incorporated under the Laws of England and Wales and a subsidiary of Orca (“Orca Bidco”, and together with its subsidiaries, the “OpSec Group”), Investcorp Technology Secondary Fund 2018, L.P., a Cayman Islands exempted limited partnership (“ITSF”), and Mill Reef Capital Fund ScS, a limited partnership (société en commandite simple) organized under the laws of Luxembourg (“Mill Reef”, and together with ITSF, the “Orca Shareholders”), pursuant to which, among other things and subject to certain terms and conditions, (1) the Orca Shareholders will contribute to Pubco all of the issued and outstanding ordinary shares of Orca (the “Orca Ordinary Shares”) in exchange for (a) ordinary shares of Pubco (“Pubco Ordinary Shares”) and (b) an aggregate amount in cash equal to $10,000,000 (collectively, the “Share Contribution” and with respect to the date it occurs, the “Share Contribution Closing”), (2) following the Share Contribution, Orca will merge with and into Merger Sub I, as a result of which the separate corporate existence of Orca shall cease and Merger Sub I shall continue as the surviving company (the “First Merger”), and (3) following the First Merger, the Company will merge with and into Merger Sub II (the “Second Merger”), as a result of which (a) the separate corporate existence of Merger Sub II shall cease and the Company shall continue as the surviving company, (b) the issued and outstanding Class A ordinary shares immediately prior to the effective time of the Second Merger (the “Second Merger Effective Time”) shall be exchanged for Pubco Ordinary Shares concurrently with the Second Merger, (c) the issued and outstanding Class B ordinary shares immediately prior to the Second Merger Effective Time shall be transferred to Pubco in exchange for Pubco Ordinary Shares and (d) the warrants of the Company outstanding immediately prior to the Second Merger Effective Time shall cease to represent a right to acquire the number of Class A ordinary shares set forth in such warrant and will instead be assumed by Pubco and automatically converted into warrants issued by Pubco (“Pubco Warrants”) to acquire an equal number of Pubco Ordinary Shares.

Table of Contents

Following consummation of the above-described transactions (the “Transactions”), the Company will be a wholly-owned subsidiary of Pubco and Orca will be a wholly-owned subsidiary of Pubco. The Transactions are expected to close in the second half of 2024, subject to customary closing conditions, including the required approval by the shareholders of the Company. Other than pursuant to the terms and conditions set forth in the Backstop Agreement, there are no other financial closing conditions of the Transactions that would preclude closing once shareholder approval is obtained.

Each Unit of the Company outstanding immediately prior to the Second Merger Effective Time shall be automatically detached and the holder thereof shall be deemed to hold one Class A ordinary share and

one-half

of a Warrant, which underlying securities shall be converted as set forth below and in accordance with the terms and conditions of the Business Combination Agreement.

At the Second Merger Effective Time, by virtue of the Second Merger and without any further action required on the part of any Party or the holders of securities of the Company or Merger Sub II:

(1)

Class

A ordinar

: Each Class A ordinary share issued and outstanding immediately prior to the Second Merger Effective Time (after giving effect to redemptions) shall be exchanged for one Pubco Ordinary Share.

(2)

Warrants

: Each warrant outstanding immediately prior to the Second Merger Effective Time shall cease to represent a right to acquire the number of Class A ordinary shares set forth in such warrant and will be exchanged for a warrant to acquire one Pubco Ordinary Share. Each of the Pubco Warrants shall have, and be subject to, substantially the same terms and conditions set forth in the Company Public Warrants.

Concurrently with the Second Merger and after giving effect to the Share Cancellation described below, the Sponsor and certain shareholders of the Company (together with the Sponsor, the “Sponsor Members”) will sell and transfer to Pubco, and Pubco will purchase, the outstanding Class B ordinary shares in exchange for an equal number of Pubco Ordinary Shares and immediately after the Second Merger Effective Time each such Class B ordinary share will be converted into a Class A ordinary share.

In connection with the Share Contribution, the Orca Shareholders will receive, in aggregate, (1) 23,577,550 Pubco Ordinary Shares, (2) an aggregate amount in cash equal to $10,000,000 and (3) the right to receive in aggregate an additional 1,277,550 Pubco Ordinary Shares upon the satisfaction of either of the following conditions (each, “Triggering Event”):

(1)

if at any time from the Second Merger Effective Time through the date that is the tenth anniversary of the Second Merger Effective Time the volume-weighted average price of Pubco Ordinary Shares is greater than or equal to $12.00 over any 20 trading days within any 30 trading day period; and

(2)

if at any time from the Second Merger Effective Time through the date that is the tenth anniversary of the Second Merger Effective Time there is a change of control of Pubco.

In connection with the Business Combination Agreement, the Company entered into the following agreements:

Backstop Agreement:

On April 25, 2023, concurrently with the execution of the Business Combination Agreement, the Sponsor, the Company, Orca and Pubco entered into a backstop agreement (the “Backstop Agreement”), pursuant to which, on the terms and subject to the conditions set forth therein, the Sponsor has committed to purchase, prior to the Second Merger Closing, equity securities of Pubco, in a private placement, for an aggregate purchase price not to exceed $50 million, to backstop certain redemptions by Shareholders of the Company.

Insider Letter Amendment:

On April 25, 2023, concurrently with the execution of the Business Combination Agreement, the Company and the Sponsor Members have entered into an amendment to that certain Letter Agreement, dated as of December 14, 2021, by and among the Company and the Sponsor Members (the “Insider Letter”), pursuant to which, among other things, the Insider Letter was amended to reduce period of time during which the Sponsor Members have agreed not to transfer their Pubco Ordinary Shares issued in respect of the exchange of their Class B ordinary shares.

Table of Contents

Sponsor Support Agreement:

On April 25, 2023, concurrently with the execution of the Business Combination Agreement, the Sponsor Members, Pubco and the Company have entered into a sponsor support agreement (the “Sponsor Support Agreement”), pursuant to which, among other things, (1) each Sponsor Member agreed (a) to vote all Ordinary Shares of the Company held by such Sponsor Member in favor of the Business Combination Agreement and the Transactions, (b) 50% of the Pubco Ordinary Shares held by such Sponsor Member as of immediately following the Second Merger Effective Time and after giving effect to the Share Cancellation (as defined below) shall be placed in escrow pursuant to an escrow agreement to be mutually agreed upon, by and among the Sponsor Members, Pubco and a mutually agreed upon escrow agent (the “Sponsor Earnout Shares”) and (c) to abstain from exercising any redemption rights in connection with the redemption of any Class A ordinary shares, and (2) the Sponsor further agreed to (a) along with certain other Sponsor Members, surrender for nil consideration and cancel immediately prior to the Share Contribution, but subject to the consummation of the Second Merger, in aggregate, 2,555,100 Class B ordinary shares held by such Sponsor Member as of immediately prior to the Share Contribution (the “Share Cancellation”), (b) transfer to the Orca Shareholders immediately following the Share Contribution, but subject to the consummation of the Second Merger, 2,050,000 Warrants held by the Sponsor and (c) reimburse the Company for expenses in excess of $20,000,000, unless such excess expenses have otherwise been approved in writing by Orca, in each case, on the terms and subject to the conditions set forth in the Sponsor Support Agreement. The Sponsor Earnout Shares shall be released from escrow pursuant to such escrow agreement and delivered to such Sponsor Member upon the occurrence of a Triggering Event.

In connection with the Closing, the Company will enter into, among others, the following agreements:

Lock-Up

Agreement:

At the Share Contribution Closing, the Orca Shareholders and Pubco shall enter into a

lock-up

agreement, pursuant to which, the Orca Shareholders agree, subject to customary exceptions, not to transfer their Pubco Ordinary Shares during the period commencing on the date of the Share Contribution Closing and ending on the earlier of (1) the date that is nine months after the Share Contribution Closing and (2) the date on which Pubco undergoes a change of control.

Registration Rights Agreement:

In connection with the Transactions, at the Second Merger Closing, and subject to the consummation thereof, (1) the registration rights agreement, dated December 14, 2021, by and among the Company and the Sponsor Members, shall be terminated and (2) Pubco, the Orca Shareholders and the Sponsor Members shall enter into a registration rights agreement, pursuant to which, among other things, the Orca Shareholders and the Sponsor Members shall be granted customary registration rights, on the terms and subject to the conditions set forth therein.

Warrant Assignment, Assumption and Amendment:

In connection with the Transactions, at or prior to the Second Merger Effective Time, the Company, Pubco and Continental will enter into a warrant assignment, assumption and amendment agreement, which amends that certain Warrant Agreement, dated December 14, 2021, by and between the Company and Continental, pursuant to which, among other things, (1) the Company will assign to Pubco, and Pubco will assume, all of the Company’s right, title and interest in and to the Warrant Agreement and (2) each warrant shall be modified to no longer entitle the holder thereof to purchase Class A ordinary shares and instead acquire an equal number of Pubco Ordinary Shares.

On December 14, 2023, the Company entered into the first amendment to the Business Combination Agreement (the “First BCA Amendment”) with Pubco, Orca and the Orca Shareholders. The First BCA Amendment provided, among other things, that (1) holders of options granted by Orca (“Orca Options”) who are not executives of Orca have the right to elect to cash out up to 10% of the Orca Options held by such holders, (2) the Orca Options granted to certain Orca executives in February of 2023 were cancelled and (3) following the consummation of the Transactions, the board of directors of Pubco will consist of seven directors, three of whom shall be “independent directors” as defined under Rule

10A-3

of the Exchange Act, with three individuals designated by Orca, two individuals designated by the Company and two individuals appointed jointly by Orca and the Company.

On March 10, 2024, the Company entered into a second amendment to the Business Combination Agreement (the “Second BCA Amendment”), which was entered into concurrently with a stock purchase agreement (the “Divestiture Agreement”) by Orca Midco and

CA-MC

Acquisition UK Ltd. (the “Divestiture Buyer”), pursuant to which, among other things, Orca Midco will sell, and the Divestiture Buyer will purchase, all of the issued and outstanding equity securities of Orca Bidco (the “Divestiture”). Prior to the execution of the Divestiture Agreement, Orca effected a reorganization of its subsidiaries pursuant to which all of the issued and outstanding equity securities of Orca Holding Denmark APS (“Orca Denmark”), the parent entity of Zacco A/S (“Zacco”), became directly owned by Orca Midco (the “Reorganization”). As a result of the Reorganization, the Divestiture will effect a sale to the Divestiture Buyer of only the Orca business, which is conducted through Orca Bidco and its subsidiaries (the “Divested Companies”), with the Zacco business being retained by Orca Midco. The Divestiture was consummated on May 7, 2024. The Company is currently evaluating whether it is in the best interests of

Table of Contents

its shareholders to continue to pursue the Business Combination after the consummation of the Divestiture, as the consummation of the Business Combination following the consummation of the Divestiture will result in the Company effecting a Business Combination with the Zacco business. In connection with the Divestiture Agreement and the Second Amendment to the BCA, the Company entered into a letter agreement, dated March 10, 2024 (the “Consent”), with Pubco, the Orca Shareholders, and Crane NXT, Co., a Delaware corporation (“NXT”), pursuant to which the Company consented to, among other things, Orca effecting the Reorganization and Orca Midco entering into the Divestiture Agreement and consummating the Divestiture. Pursuant to the Consent, the Company also releases, relinquishes and discharges any and all existing or potential claims, causes of action and damages (i) against NXT and its affiliates solely in respect of matters relating to the Divestiture arising or occurring prior to the execution of the Divestiture Agreement, and (ii) if the Divestiture is consummated, against the Divested Companies, solely in respect of matters related to the Reorganization, the Divestiture, the Letter Agreement (as defined in the Consent) and the Business Combination Agreement.

In connection with the Reorganization and the Divestiture, the Second BCA Amendment provides for, among other things, (i) that the net proceeds from the Divestiture be deposited in a third-party escrow account and the terms by which such proceeds may be released, (ii) a transition services agreement, (iii) a fairness opinion and (iv) the conversion of Class B ordinary shares, which was elected on December 22, 2023 and effected on January 2, 2024.

On May 3, 2024, the Company entered into that certain Third Amendment to the Business Combination Agreement (the “Third BCA Amendment”) with Pubco, Orca and the Orca Shareholders. The Third BCA Amendment provides, among other things, that: (a) the Purchase Price for the Divestiture that will be deposited into the Divestiture Proceeds Escrow Account if the Divestiture is consummated prior to the Second Merger Closing will be reduced by certain fees, costs and expenses as set forth on Schedule IX of the Business Combination Agreement (the “Specified Transaction Expenses”); (b) concurrently with or promptly following the consummation of the Divestiture, the Specified Transaction Expenses shall be paid to the payees in the amounts set forth on Schedule IX of the Business Combination Agreement, and, if the Share Contribution is consummated, such advance of the Specified Transaction Expenses shall be treated as a partial payment by Orca Midco of Pubco’s obligation to bear the Expenses of the Target Companies in accordance with the terms of the Business Combination Agreement; (c) promptly following the consummation of the Divestiture, Pubco, Orca Midco and the Company shall instruct the Escrow Agent to release from the Divestiture Proceeds Escrow Account to the Company (or such other person as the Company directs) an amount equal to $7,800,000 in connection with the settlement of the Company’s Expenses (the “Specified Company Transaction Expenses”), and, if the Share Contribution is consummated, such advance of the Specified Company Transaction Expenses shall be treated as a partial payment by Orca Midco of Pubco’s obligation to bear the Company’s Expenses in accordance with the terms of the Business Combination Agreement; (d) Orca Midco shall have the right to receive an advance from the funds held in the Divestiture Proceeds Escrow Account in an amount equal to (i) the First Distribution Amount of $3,000,000 if the Second Merger Closing has not occurred prior to May 28, 2024 and (ii) the Second Distribution Amount of $73,800,000 less the First Distribution Amount to the extent the First Distribution Amount has been released to Orca Midco prior to the release of the Second Distribution Amount to Orca Midco pursuant to and in accordance with the terms of the Business Combination Agreement, if the Second Merger Closing has not occurred prior to August 26, 2024; (e) in the event that the Special Committee has determined in good faith, after consultation with its outside legal counsel and other advisors, that the consummation of the Transactions following the consummation of the Divestiture is not in the best interests of the Company and the Company’s shareholders holding Class A ordinary shares (other than Sponsor) in accordance with the Cayman Companies Act, the Company shall have the right to terminate the Business Combination Agreement during the period following the consummation of the Divestiture and ending on and including August 10, 2024 (which was later amended to August 30, 2024 in the Fourth Amendment to the Business Combination Agreement entered into on August 4, 2024 as discussed in Note 13 – Subsequent Events); (f) (i) upon a termination of the Business Combination Agreement by the Company or Orca due to the failure of the Transactions to be consummated by the Outside Date or (ii) upon a termination of the Business Combination Agreement by the Company or Orca due to a governmental order that permanently prohibits the consummation of the Transactions, the Termination Amount payable to the Company shall be $30,000,000 so long as written notice of such termination is provided during the period following the Divestiture Closing and ending on and including August 10, 2024; and (g) the Termination Amount to be paid by Orca Midco to the Company upon certain terminations of the Business Combination Agreement shall be reduced by the amount of the Specified Company Transaction Expenses plus notional interest accruing daily from the date the Specified Company Transaction Expenses are advanced to the Company (or such other person as the Company directs) up to and including the date of termination of the Business Combination Agreement at a rate of 8% per annum.

Table of Contents

Divestiture Proceeds

The Divestiture was consummated on May 7, 2024 and concurrently with the consummation of the Divestiture, Orca Midco caused the net proceeds of the Divestiture (the “Divestiture Proceeds”) to be deposited into a third-party escrow account (the “Divestiture Proceeds Escrow Account”) with an escrow agent reasonably acceptable to the Company. Such Divestiture Proceeds shall be held in the Divestiture Proceeds Escrow Account pursuant to an escrow agreement entered into by and among Orca Midco, Pubco, the Company and the escrow agent, in form and substance acceptable to the Company (the “Divestiture Proceeds Escrow Agreement”), such escrow agent holding such funds as nominee of and for the benefit of Orca Midco, the Company or Pubco, as applicable, subject always to the terms of the Business Combination Agreement and the Divestiture Proceeds Escrow Agreement. The Divestiture Proceeds shall be released from escrow and payable to (a) Pubco upon the Second Merger Closing, (b) the Company upon certain termination events as described further in the section below entitled “Termination” or (c) Orca Midco (i) upon an amount becoming due and payable by Orca Midco in accordance with the terms of the Divestiture Agreement, with such amount being subject to the review and reasonable confirmation of the Company, or (ii) in connection with a Proceeds Advance (as defined below) as described further in the section below entitled “Proceeds Advance”. The Company is a third-party beneficiary of the provisions of the Divestiture Agreement that give effect to the foregoing.

If the funds from the Divestiture Proceeds Escrow Account are released to Pubco, Pubco will use such funds to (a) promptly pay (or cause to be promptly paid) all of the Company’s Expenses, and (b) within 14 days following the Second Merger Closing, to the extent permitted by applicable Law and subject to the determination of the Pubco Board that it is in the best interests of the holders of Pubco Ordinary Shares, make a dividend to all holders of Pubco Ordinary Shares in such amount as determined by the Pubco Board, which such dividend shall be paid in cash or, at the election of the applicable holder of such Pubco Ordinary Shares, in kind in Pubco Ordinary Shares. If declared, such dividend shall not be less than an amount as is necessary to enable ITSF to receive dividends in an amount which is, in the aggregate, equal to the amount of any Proceeds Advance. In lieu of a dividend, the Pubco Board may also approve and effect a tender offer, repurchase of shares or other similar process by which the holders of Pubco Ordinary Shares receive the same economic benefit (including as regards the receipt of cash proceeds) as if a dividend had been declared.

In the event that the Proposed Transactions have not been consummated by August 26, 2024, Orca Midco will be provided an advance from the Divestiture Proceeds held in the Divestiture Proceeds Escrow Account (a “Proceeds Advance”) pursuant to a promissory note in form and substance acceptable to IVC Europe in the principal amount of $73,800,000. The promissory note will contain the same terms, structure and conditions, including interest rate, security and guarantees, as ITSF’s current debt facility. The purpose of the Proceeds Advance is solely to enable ITSF to satisfy its obligations under such facility for which payment will have been triggered by the consummation of the Divestiture. Once the Proposed Transactions have been consummated, the outstanding balance under the Promissory Note will be set off against any shareholder distributions made by Pubco which would otherwise have been payable to ITSF.

Divestiture Transition Matters

OpSec Services India Private Limited (an indirect subsidiary of Zacco) (“Zacco India”) and OpSec Online LLC (an indirect subsidiary of Orca Bidco) (“OpSec Online”) entered into a transitional services agreement on May 3, 2024 in connection with the divestiture of the OpSec Group to Crane. Pursuant to the agreement, Zacco India agreed to provide certain transitional services, including operations, HR, IT and paralegal support services, to OpSec Online, for a period of between 3 and 6 months following completion of the Divestiture. In addition, the agreement provides that certain employees providing certain of the TSA services relating to the OpSec Group’s Indian operations will transfer their employment to the OpSec Group within 6 months of the Divestiture.

Each of Dr. Selva Selvaratnam, the CEO of the Pubco, and Bev Dew, the CFO of the Pubco, entered into side letters with Orca Midco and Crane on March 10, 2024 pursuant to which it was agreed that (i) Dr. Selvaratnam would be permitted to continue to serve as a director of each of Orca Holdings Denmark ApS and Zacco A/S for an unlimited duration, and (ii) Bev Dew would be permitted to continue to serve as a director of Orca Midco until December 17, 2024 (or such other date as may be agreed in writing between the parties). Each of Dr. Selvaratnam and Bev Dew have further agreed in writing to take any reasonable actions directed by the applicable boards on which they continue to serve in connection with the consummation of the transactions contemplated by the Business Combination Agreement.

Fairness Opinion

Following the execution of the Second BCA Amendment, the Company will use commercially reasonable efforts to obtain from an independent valuation firm a customary opinion that the exchange ratio, after giving effect to the consummation of the Divestiture and the consummation of the Transactions, is fair, from a financial point of view, to the Company’s public shareholders holding Class A ordinary shares (other than Sponsor) (the “Fairness Opinion”).

Table of Contents

In the event that the Company is unable to obtain the Fairness Opinion, (a) the number of Pubco Ordinary Shares issuable to the Orca Shareholders at the Share Contribution Closing and (b) the number of Sponsor’s Founder Shares subject to the Share Cancellation shall be adjusted, in each case, to reflect an enterprise value (on a debt free, cash free basis) of the Zacco companies of $160,000,000 (subject to an increase or decrease by up to $16,000,000 to reflect the enterprise value stated in the Fairness Opinion); provided, that (i) any adjustments made pursuant to the foregoing clauses (a) and (b) are made pro rata and only to the extent necessary to enable the independent valuation firm to deliver the Fairness Opinion, and (ii) for the purposes of clause (b), all Founder Shares shall be treated as fully vested.

Representations and Warranties; Covenants

The Second BCA Amendment adds certain representations and warranties with respect to Zacco and its subsidiaries, including with respect to (a) its material contracts, (b) its ownership of intellectual property, (c) its top customers and suppliers and (d) the sufficiency of the assets of Zacco and its subsidiaries for the operation of the Zacco business. The Second BCA Amendment also requires Orca to deliver a supplement to their disclosure schedules within 14 days of the execution of the Second BCA Amendment, which supplement will provide additional disclosures regarding the Zacco business.

The Second BCA Amendment also added certain covenants regarding the operation of the Zacco business between the signing of the Second BCA Amendment and the consummation of the Transactions. Additionally, the covenants regarding the operation of Orca and its subsidiaries have been amended to permit the Divestiture in accordance with the terms and subject to the conditions set forth in the Divestiture Agreement. Furthermore, Orca will be required to deliver, as soon as reasonably practicable following the execution of the Second BCA Amendment, to Pubco and the Company (a) audited financial statements of the Zacco business for fiscal years 2022 and 2023 and (b) pro forma financial statements of Orca reflecting the acquisition of the Zacco business and the Divestiture.

Termination

The Second BCA Amendment adds a new right to terminate the Business Combination Agreement in favor of the Company in the event that (a) the Company is unable to obtain the Fairness Opinion or (b) the Special Committee has determined in good faith, after consultation with its outside legal counsel and other advisors, that the consummation of the Transactions following the consummation of the Divestiture is not in the best interests of the Company and the Company’s shareholders holding Class A ordinary shares (other than Sponsor) in accordance with the Cayman Companies Act. Such termination right may only be exercised by the Company within the two week period following the consummation of the Divesture (the “Post- Divestiture Termination Period”).

The Second BCA Amendment also requires that certain amounts be paid by Orca to the Company upon certain terminations of the Business Combination Agreement which amounts must be paid upon the earlier of (a) the consummation of the Divestiture and (b) the Extended Date.

The amounts payable to the Company and the termination events triggering their payment are: (a) upon a termination by the Company or Orca due to the failure of the Transactions to be consummated by the Extended Date, (i) $30,000,000 if such termination occurs during the Post-Divestiture Termination Period, and (ii) $25,000,000 if such termination occurs at any other time, in each case, so long as the Company is not the cause of such failure; (b) upon a termination by the Company or Orca due to a governmental order that permanently prohibits the consummation of the Transactions, (i) $30,000,000 if such termination occurs during the Post-Divestiture Termination Period, and (ii) $25,000,000 if such termination occurs at any other time, in each case, so long as the Company is not the cause of such governmental order; (c) upon a termination by the Company due to a material breach of the Business Combination Agreement by Orca or the Orca Shareholders, $30,000,000 (or, alternatively, the Company may initiate an action against Orca and/or the Orca Shareholders to seek damages); and (d) upon a termination by the Company due to either (i) the inability of the Company to obtain the Fairness Opinion or (ii) a good faith determination by the Special Committee, after consultation with its outside legal counsel and other advisors, that the consummation of the Transactions following the consummation of the Divestiture is not in the best interests of the Company and the Company’s shareholders holding Class A ordinary shares (other than Sponsor) in accordance with the Cayman Companies Act, $30,000,000. Except for any amounts payable to the Company described in clause (d) above, all termination amounts payable to the Company shall be due and payable when such amounts have been (A) agreed in writing by the Company and Orca or (B) determined by a court of competent jurisdiction.

Table of Contents

Proceeds Advance

In the event that the Divestiture has been consummated and the Transactions have not been consummated by August 26, 2024, Orca Midco shall be provided an advance from the Divestiture Proceeds held in the Divestiture Proceeds Escrow Account (a “Proceeds Advance”) pursuant to a promissory note in form and substance acceptable to the Company in the principal amount of $73,800,000 on the same terms, structure and conditions, including, but not limited to, interest rate, security and guarantees, as ITSF’s current facility (the “Promissory Note”) to enable ITSF to satisfy its obligations under such facility for which payment will have been triggered by the consummation of the Divestiture. Once the Transactions have been consummated, the outstanding balance under the Promissory Note will be set off against any shareholder distributions made by Pubco which would otherwise have been payable to ITSF.

Conversion of Class B Ordinary Shares

The Second BCA Amendment provides for the conversion of the Class B ordinary shares into Class A ordinary shares, which was elected on December 22, 2023 and effected on January 2, 2024.

Subscription Agreement

On December 15, 2023, the Company entered into a subscription agreement (the “Subscription Agreement”) with Pubco, Orca, and Sakata INX Corporation, a Japanese corporation (the “Subscriber”). Pursuant to the Subscription Agreement, the Subscriber subscribed for 5,000,000 unsecured convertible loan notes (the “Loan Notes”) of $1.00 each issued by Orca for an aggregate purchase price of $5,000,000 (the “Note Subscription”). On the terms and subject to the conditions set forth in the Loan Notes, including the consummation of the First Merger, the Loan Notes will automatically be novated from Orca to Pubco and simultaneously will convert into 526,316 Pubco Ordinary Shares (the “Subscription Shares”), par value $0.0001 per share (the “Share Subscription”). The closing of the Share Subscription will occur following the consummation of the First Merger and before the Second Merger (the “Closing”).

The Subscription Agreement will terminate upon the earlier to occur of (1) such date and time as the Business Combination Agreement is validly terminated in accordance with its terms, (2) upon the mutual written agreement of each of the parties to the Subscription Agreement, (3) if any of the conditions to the Closing are not satisfied, or are not capable of being satisfied, on or prior to the Closing, and as a result thereof, the transactions contemplated by the Subscription Agreement will not be and are not consummated at the Closing and (4) one year from the date of the execution of the Subscription Agreement if the closing of the Business Combination has not occurred.

Pursuant to the Subscription Agreement, Pubco has granted the Subscriber customary registration rights, on the terms and subject to the conditions set forth therein.

At the Closing, Pubco and the Subscriber will enter into a

lock-up

agreement, pursuant to which the Subscriber agrees, subject to customary exceptions, not to transfer the Subscription Shares during the period commencing on the date on which the Closing occurs and ending on the earlier of (1) the date that is 12 months after the Closing and (2) the date on which Pubco undergoes a change of control.

Note 5—Private Placement Warrants

Simultaneously with consummation of the IPO, the Sponsor purchased an aggregate of 16,700,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant ($16,700,000 in the aggregate). Each whole Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Extension Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.

Note 6—Related Party Transactions

Founder Shares

On April 1, 2021, the Sponsor purchased 8,625,000 shares of the Company’s Class B ordinary shares (the “Founder Shares”) for an aggregate purchase price of $25,000. On November 3, 2021, the Sponsor transferred 718,750 Founder Shares to Baroness Ruby McGregor-Smith, 479,167 Founder Shares to Peter McKellar, and 30,000 Founder Shares to each of Pam Jackson, Laurence Ponchaut and Adah Almutairi, at approximately $0.12 per share. On December 14, 2021, in connection with the increase in the size of the IPO, the Company effected a capitalization increasing the number of Founder Shares held by each initial shareholder by 20%, thereby increasing the aggregate number of issued and outstanding Founder Shares to 8,625,000. This resulted in a benefit to the Company from the excess fair value of shares issued over the nominal purchase price. The excess fair value of the Founder Shares over their nominal purchase price is estimated to be $5,292,600 and will be recorded as compensation expense upon closing of the Business Combination.

Table of Contents

The Sponsor and the Company’s directors and executive officers have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary share equals or exceeds $12.00 per share (as adjusted for share

sub-divisions,

share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading

day period commencing at least 120 days after a Business Combination, or (y) if the Company consummates a transaction after the initial Business Combination which results in shareholders having the right to exchange their shares for cash, securities or other property.

On December 22, 2023, and effected on January 2, 2024, the Sponsor and certain directors and officers of the Company voluntarily elected to convert an aggregate 8,624,999 Class B ordinary shares to Class A ordinary shares, par value $0.0001 per share, of the Company, on a

one-for-one

basis in accordance with the Articles. Following this conversion, there was 1 Class B ordinary share outstanding and 8,624,999 Class A ordinary shares that are

non-redeemable.

Related Party Loans

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor may, but is not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. At the lender’s discretion, up to $2,000,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The terms of the warrants would be identical to the terms of the Private Placement Warrants.

On March 7, 2023, the Company entered into

a non-interest bearing

convertible unsecured loan (the “March 2023 Loan”) in the principal amount of up to $2,000,000 from one of the Sponsor’s affiliates to provide the Company with additional working capital and to fund the Extension Contributions. The March 2023 Loan constitutes a Working Capital Loan as defined above. The portion of the Loan used to provide the Company with additional working capital was not deposited into the Trust Account. If the Company does not consummate an initial Business Combination during the Extension Period, the March 2023 Loan will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The March 2023 Loan is convertible into private placement warrants of the post-Business Combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. The conversion option represents an embedded derivative under ASC

815-15,

In addition, on July 6, 2023, November 15, 2023, November 27, 2023, April 15, 2024 and June 6, 2024, the Company entered into

non-interest

The total amount outstanding under the Loans entered into described above as of June 30, 2024 was $6,450,000, of which $4,050,000 was utilized as Extension Contributions. As of December 31, 2023, there was $4,750,000 outstanding under the Loans, of which $3,300,000 was utilized as Extension Contributions.

Note 7—Loan Payable to Target

On May 3, 2024, in connection with the Third Amendment to the Business Combination Agreement, the Divestiture Escrow Account paid $7.8 million to the Company’s legal advisor as settlement of renegotiated fees incurred through that time (See Note 11). The $7.8 million represented the Specified Transaction Expenses contemplated in the Third Amendment to the Business Combination Agreement. In the event that the Business Combination is not consummated, these fees would be due back to the Divestiture Escrow Account with interest of 8% per annum.

Table of Contents

As the Business Combination is not considered probable, the Company has set up the amount owed as a note payable. As of June 30, 2024, the Company has accrued $99,180 in interest expense related to this note payable.

Note 8—Class A

rdinary Shares Subject to Possible Redemption

Class

A Ordinary Shares—

The Company is authorized to issue 400,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of June 30, 2024 and December 31, 2023, there were 8,624,999 Class A ordinary shares issued or outstanding (excluding 9,385,685 and 11,545,295 shares subject to possible redemption).

On March 14, 2023 at the First Extraordinary General Meeting, holders of Public Shares were afforded the opportunity to require the Company to redeem their Public Shares for their pro rate share of the Trust Account. 15,494,333 out of 34,500,000 Public Shares were redeemed at a redemption price of approximately $10.43 per share, leaving 19,005,667 Public Shares remaining outstanding.

On December 5, 2023, at the Second Extraordinary General Meeting, holders of Public Shares were afforded the opportunity to require the Company to redeem their Public Shares for their pro rata share of the Trust Account. At the Second Extraordinary General Meeting, 7,460,372 out of 19,005,667 Public Shares were redeemed at a redemption price of $11.00 which left 11,545,295 shares outstanding.

On May 21, 2024, at the Third Extraordinary General Meeting, holders of Public Shares were afforded the opportunity to require the Company to redeem their public Shares for their pro rata share of the Trust Account. At the Third Extraordinary General Meeting, 2,159,610 out of 11,545,295 Public Shares were redeemed at a redemption price of $11.32 which left 9,385,685 shares outstanding.

Note 9—Shareholders’ Deficit

Preference Shares

—The Company is authorized to issue 1,000,000 preference shares, with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2024 and December 31, 2023, there were

preference shares issued or outstanding.

Class

B Ordinary Shares

—The Company is authorized to issue 40,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of June 30, 2024 and December 31, 2023, there was one Class B ordinary share issued and outstanding.

Holders of Ordinary Shares will vote together as a single class on all matters submitted to a vote of shareholders except as required by law.

one-for-one

basis in accordance with the Articles. Following this conversion, there was one Class B ordinary share outstanding.

All of the terms and conditions applicable to the Class B ordinary shares set forth in the letter agreement, dated December 14, 2021 and as amended on April 25, 2023 and December 11, 2023, by and among the Company, its officers, its directors and the Sponsor (the “Letter Agreement”), shall continue to apply to the Class A ordinary shares into which the Class B ordinary shares converted, including the voting agreement, transfer restrictions and waiver of any right, title, interest or claim of any kind to the Trust Account (as defined in the Letter Agreement) or any monies or other assets held therein.

Note 10—Warrant Liabilities

Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination.

Table of Contents

The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable, and the Company will not be obligated to issue any Class A ordinary shares upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Warrants.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement of which this prospectus forms a part or a new registration statement for the registration, under the Securities Act, of Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of a Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if the Class A ordinary share is at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but it will use its commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Redemption of warrants when the price per Class

ordinary share equals or exceeds $18.00.

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

•

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a

30-trading

day period ending

three trading days

before the Company sends the notice of redemption to the warrant holders.

If and when the Public Warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of warrants when the price per Class

A ordinary share equals or exceeds $10.00.

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

•

in whole and not in part;

•

at a price of $0.10 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A ordinary shares;

•

if, and only if, the Reference Value (as defined above under “—Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00”) equals or exceeds $10.00 per share (as adjusted for share

sub-divisions,

share dividends, reorganizations, recapitalizations and the like); and

•

if the Reference Value is less than $18.00 per share (as adjusted for share

sub-divisions,

share dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.

In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from

Table of Contents

such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described adjacent to “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the IPO, except that the Private Placement Warrants and Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be

non-redeemable

so long as they are held by the initial purchasers or their permitted transferees (except for a number of Class A ordinary shares as described above under Redemption of warrants for Class A ordinary shares). If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants.

The Company accounts for the 33,950,000 warrants to be issued in connection with the IPO (including 17,250,000 Public Warrants and 16,700,000 Private Placement Warrants) in accordance with the guidance contained in ASC

815-40.

Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. The warrant agreement contains an Alternative Issuance provision that if less than 70% of the consideration receivable by the holders of the Class A ordinary shares in the Business Combination is payable in the form of equity in the successor entity, and if the holders of the warrants properly exercises the warrants within thirty days following the public disclosure of the consummation of Business Combination by the Company, the warrant price shall be reduced by an amount equal to the difference.

Note 11—Commitments & Contingencies

Registration Rights

The holders of the Founder Shares and Private Placement Warrants (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights and shareholder agreement to be signed prior to or on the Effective Date of the IPO, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters were granted the option to purchase up to 4,500,000 additional Units at the IPO price of $10.00 within 45 days of the consummation of the IPO. The underwriters fully exercised this option at the time of the IPO. The underwriters earned a cash underwriting discount of $0.20 per Unit, or $6,900,000 in the aggregate, which was paid upon the closing of the IPO.

In addition, the underwriters will be entitled to a deferred fee of $0.35 per Unit, or $12,075,000 in the aggregate, with each entitled to $6,037,500. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

On June 10, 2024, one of the Company’s underwriters resigned and provided a waiver of expenses and fees. Accordingly, the Company reversed the $6,037,500 liability, which represented their portion of the full $12,075,000.

Legal Fees

The Company had an agreement in place whereby if its legal counsel assists in the Business Combination efforts and the Business Combination is successful, it could receive up to $893,755 (the “Success Fee”). The Success Fee would only become due and payable in the event of a successful Business Combination. In accordance with ASC 805, Business Combinations, this fee was not going to be recorded until such time as a Business Combination is consummated.

Table of Contents

On May 3, 2024, the Company renegotiated its fees, inclusive of all unbilled fees incurred through April 30, 2024 as well as the Success Fee, with its legal counsel. As a result of such negotiation, the Company negotiated a fee of $7.8 million for all incurred services and agreements prior to that date with an additional $1.8 million deferred to the closing of a successful Business Combination.

The $7.8 million in renegotiated fees was paid to the legal advisor from the Divestiture Escrow account and as such it is a loan included in the Note Payable to Target account on the balance sheet (see Note 7).

The Company retained the $1.8 million fee on its balance sheet in Accounts payable and accrued expenses as the fee is for time and services already incurred by the legal advisor. Further, as a result of this renegotiation, the Company recognized a gain related to the renegotiation of legal fees in the amount of $2.5 million in the statement of operations.

From the date of the agreement forward, the legal advisor will continue to accrue fees at their previously agreed upon rate.

Consulting Agreements

In April 2023, the Company entered into two agreements with each of the IPO underwriters, each to act as a capital markets advisor and as a placement agent in relation to the Business Combination. On June 9, 2023, the Company terminated the two engagement letters with one of the IPO underwriters, and such termination nullified the Company’s obligation to pay any fees under such agreements. With respect to the other IPO underwriter, as compensation for their services, half of a placement fee of 3.0% of the gross proceeds of securities sold in the placement was to be paid to the agent upon consummation of the placement (the “Placement Fee”) and $4,000,000 was to be paid to the agent upon consummation of the Business Combination (the “Transaction Fee”). The Placement Fee and the Transaction fee would only have become payable in the event the placement and the Business Combination were consummated, respectively, and as such nothing will be recorded until that time. On June 10, 2024, the other IPO underwriter resigned and waived the obligation to any fees. As such, the Placement and Transaction Fees will not become payable.

In June 2023, the Company entered into an agreement with a third-party consultant to provide advisory services in relation to the Business Combination. On July 15, 2024, the Company terminated the agreement with the third-party consultant and entered into a new agreement with the third-party consultant. As a result, and as compensation for those services, an advisory fee of $3,000,000 is payable in the event the transaction is consummated (the “Advisory Fee”). This fee will only become payable in the event the Business Combination is consummated and as such nothing will be recorded until that time.

Additionally, the consultant was eligible to receive a termination fee of $500,000 and to be reimbursed in the aggregate up to $500,000 in expenses in the event the Business Combination is not consummated. As part of the termination of the initial agreement, the consultant billed $1,185,488 in connection with its fees incurred. As of June 30, 2024, $1,185,488 is accrued in the Accounts Payable and Accrued Expenses line on the balance sheet.

Note 12—Recurring Fair Value Measurements

The following table sets forth by level within the fair value hierarchy the Company’s assets and liabilities that were accounted for at fair value on a recurring basis as of June 30, 2024 and December 31, 2023:


As of June 30, 2024	(Level 1)		(Level 2)		(Level 3)
Assets
Cash held in Trust Account	$	106,759,103	$	—	$	—
Liabilities
Public Warrants		1,251,000		—		—
Private Placement Warrants		—		—		1,211,000

Total	$	108,010,103	$	—	$	1,211,000


As of December 31, 2023	(Level 1)		(Level 2)		(Level 3)
Assets
Cash held in Trust Account	$	127,703,238	$	—	$	—
Liabilities
Public Warrants		3,954,000		—		—
Private Placement Warrants		—		—		3,828,000

Total	$	131,657,238	$	—	$	3,828,000

Table of Contents

Cash held in Trust Account

As of June 30, 2024, the assets held in the Trust Account were held in a bank account. On December 14, 2023, in order to mitigate the potential risks of being deemed to have been operating as an unregistered investment company for purposes of the Investment Company Act, the Company instructed Continental to liquidate the U.S. government treasury obligations and money market funds held in the Trust Account and to hold all funds in the Trust Account in cash in an interest-bearing bank demand deposit account until the earlier of consummation of the Company’s initial Business Combination or liquidation.

During the period from March 22, 2021 (inception) through June 30, 2024, the Company did not withdraw any of the interest income from the Trust Account to pay its tax obligations.

The composition of the Company’s fair value of assets held in the Trust Account on June 30, 2024 and December 31, 2023 is as follows:


	Fair Value as of June 30, 2024	Fair Value as of December 31, 2023
Cash held in Trust Account	$106,759,103	$127,703,238

Warrant Liabilities

As of June 30, 2024, the Company’s warrant liabilities were valued at $2,462,000. Under the guidance in ASC

815-40,

the Public Warrants and the Private Placement Warrants do not meet the criteria for equity treatment. As such, the Public Warrants and the Private Warrants must be recorded on the balance sheet at fair value. This valuation is subject to

re-measurement

at each balance sheet date. With each

re-measurement,

the valuations will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.

The Company’s warrant liability is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the warrant liabilities is classified within Level 3 of the fair value hierarchy.

The Company established the initial fair value for the warrants on December 17, 2021, the date of the consummation of the Company’s IPO. The fair value of the Public Warrants and the Private Placement Warrants were measured using a Monte Carlo simulation model. The estimated fair value of the Public Warrants and the Private Placement Warrants were determined using Level 3 inputs. The Monte Carlo simulation utilizes certain known inputs such as the Company’s stock price, the warrant exercise price, the time to expiration and the fact that there is a call condition. The risk-free interest rate is based on the U.S. Treasury curve. The expected life of the instruments are assumed to be equivalent to their remaining contractual term plus the amount of time assumed to consummate a Business Combination. Additionally, inherent in a Monte Carlo simulation model is an assumption related to the unknown expected share-price volatility. The Company estimates the implied volatility of its warrants based on the volatility required to produce a model price equal to the market price for the Company’s Public Warrants.

The following table presents a summary of the changes in the fair value of the Warrants liabilities classified as Level 3, measured on a recurring basis.


	Private Warrant Liability
Fair Value as of December 31, 2023	$	3,828,000
Change in fair value		(3,243,000	)

Fair Value as of March 31, 2024		584,500
Change in fair value		626,500

Fair Value as of June 30, 2024	$	1,211,000

Table of Contents

The following table provides the significant inputs into the Monte Carlo method for the fair value of the Private Warrants:


Input	6/30/2024			12/31/2023
Share price	$	11.35		$	11.02
Exercise price	$	11.50		$	11.50
Risk-free rate of interest		4.33	%		3.84	%
Volatility		0.001	%		15.88	%
Term (in years)		5.21			5.06
Dividend yield		—	%		—	%

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. The Public Warrants underlying the Units sold in the IPO began separately trading on February 3, 2022 and as such were reclassified to Level 1 in the quarter ended March 31, 2022. There were no other transfers in or out of Level 3 from other levels in the fair value hierarchy for the three and six months ended June 30, 2024.

Note 13—Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on this review, the Company did not identify any subsequent events, other than those detailed below, that would have required adjustment or disclosure in the financial statement.

On August 1, 2024, Investcorp Europe Acquisition Corp I (the “Company”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that since the Company’s aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the “Notice”). The Notice additionally indicates that the Company, pursuant to the Listing Rules, has 45 calendar days, or until September 16, 2024, to submit a plan to regain compliance. If Nasdaq accepts the Company’s plan, the Company will have 180 calendar days from the date of the Notice, or until January 29, 2025, to evidence compliance. If Nasdaq were to reject the Company’s plan, Nasdaq rules permit the Company to appeal the decision to a hearings panel.

On August 4, 2024, the Company entered into a Fourth Amendment to the Business Combination Agreement (the “Fourth BCA Amendment” and, the Original Business Combination Agreement, as amended by the First BCA Amendment, the Second BCA Amendment, the Third BCA Amendment and the Fourth BCA Amendment, the “Business Combination Agreement”) with Pubco, Orca and the Orca Shareholders. The Fourth BCA Amendment provides, among other things, that: (a) promptly following the execution and delivery of the Fourth BCA Amendment, Pubco, Orca Midco and the Company shall instruct the Escrow Agent to release from the Divestiture Proceeds Escrow Account to the Company (or such other person as the Company directs) an amount equal to $1,195,642.84 in connection with the settlement of certain of the Company’s Expenses (the “Additional Specified Company Transaction Expenses”), and, if the Share Contribution is consummated, such advance of the Additional Specified Company Transaction Expenses shall be treated as a partial payment by Orca Midco of Pubco’s obligation to bear the Company’s Expenses in accordance with the terms of the Business Combination Agreement; (b) the right to terminate the Business Combination Agreement that may be exercised by the Company if the Special Committee has made an Intervening Event Recommendation Change due to (i) the inability of the Company to obtain the Fairness Opinion or (ii) the good faith determination by the Special Committee, after consultation with its outside legal counsel and other advisors, that the consummation of the Transactions following the Divestiture Closing is not advisable, fair to and in the best interests of the Company and the Company’s shareholders holding SPAC Class A Shares (other than Sponsor) in accordance with the Cayman Companies Act is extended to the period beginning on the Divestiture Closing and ending on and including August 30, 2024; (c) upon a termination of the Business Combination Agreement by the Company or Orca due to a governmental order that permanently prohibits the consummation of the Transactions, the Termination Amount payable to the Company shall be $30,000,000 so long as written notice of such termination is provided during the period following the Divestiture Closing and ending on and including August 30, 2024; and (d) the Termination Amount to be paid to the Company upon certain terminations of the Business Combination Agreement shall be further reduced by the amount of the Additional Specified Company Transaction Expenses plus notional interest accruing daily from the date the Additional Specified Company Transaction Expenses are advanced to the Company (or such other person as the Company directs) up to and including the date of termination of the Business Combination Agreement at a rate of 8% per annum.

Table of Contents

On August 4, 2024, concurrently with the execution of the Fourth BCA Amendment, the Company entered into (a) a loan agreement (the “Transaction Expenses Loan Agreement”) pursuant to which Orca Midco made available to the Company an interest bearing loan in the principal amount of $7,800,000 in respect of the SPAC Specified Transaction Expenses contemplated in, and advanced to the Company in connection with the execution of, the Third BCA Amendment (the “Transaction Expenses Loan”), and (b) a loan agreement (the “Additional Transaction Expenses Loan Agreement” and, together with the Transaction Expenses Loan Agreement, the “Loan Agreements”) pursuant to which Orca Midco made available to the Company an interest bearing loan in the principal amount of $1,195,642.84 in respect of the Additional Company Specified Transaction Expenses (the “Additional Transaction Expenses Loan” and, together with the Transaction Expenses Loan, the “Loans”). The Company shall pay interest on the Loans at a rate of 8% per annum. The interest on each Loan shall (i) accrue daily, (ii) compound annually on December 31 of each year and be added to the unpaid principal amount of such Loan and (iii) be payable upon the repayment date of such Loan. Each Loan shall be due and payable on the fifth anniversary of the execution of the applicable Loan Agreement.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

All statements other than statements of historical fact included in this report including, without limitation, statements under “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. When used in this report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or the Company’s management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Overview

We are a blank check company incorporated on March 22, 2021 as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or assets. We have signed a Business Combination Agreement with our selected Business Combination target as of April 25, 2023. We intend to effectuate our initial business combination using cash from the proceeds of our IPO and the private placement of the Private Placement Warrants, the proceeds of the sale of our shares in connection with our initial Business Combination, shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.

The issuance of additional shares in connection with a Business Combination to the owners of the target or other investors:

•

may significantly dilute the equity interest of investors in our IPO, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares;

•

may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares;

•

could cause a change in control if a substantial number of our Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

•

may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and

•

may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants. Similarly, if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result in:

•

default and foreclosure on our assets if our operating revenues after an initial Business Combination are insufficient to repay our debt obligations;

•

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

•

our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;

•

our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;

•

our inability to pay dividends on our Class A ordinary shares;

•

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;

•

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

•

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and

•

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

Results of Operations and Known Trends or Future Events

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities and activities related to searching for a target for our Business Combination. We will not generate any operating revenues until after completion of our initial Business Combination. We generate non-operating income in the form of interest income on cash and cash equivalents.

For the three months ended June 30, 2024, we had a net loss of $899,833, which consisted of a $1,273,750 loss on the change in fair value of warrant liabilities, $99,180 in interest expense and $3,355,845 in formation and operating costs, offset by $1,282,016 in interest income on Cash held in Trust Account and a $2,546,926 gain in forgiveness of legal fees. For the six months ended June 30, 2024, we had net income of $3,656,692, which consisted of $2,685,613 in interest income on Cash held in Trust Account, a $5,320,000 gain on the fair value of warrant liabilities and a $2,546,926 gain in forgiveness of legal fees, offset by $6,796,667 in formation and operating costs and $99,180 in interest expense.

For the three months ended June 30, 2023, we had a net loss of $3,752,723, which consisted of a $3,249,935 loss on the change in fair value of warrant liabilities, and $2,885,101 in formation and operating costs, offset by $2,382,313 in interest income on Marketable Securities held in Trust Account. For the six months ended June 30, 2023, we had a net loss of $5,869,034, which consisted of a $5,264,750 loss on the fair value of warrant liabilities, and $6,595,415 in formation and operating costs, offset by $5,991,131 in interest income on Marketable Securities held in Trust Account. The high level of operating costs in the three month and six month periods reflects due diligence work related to evaluating the business combination ahead of the announcement in April 2023, legal expenses related to finalizing the Business Combination Agreement and additional legal expenses related to the business combination in the period since the Business Combination Agreement was signed.

Liquidity and Capital Resources

Our liquidity needs have been satisfied through receipt of $25,000 from the sale of the Founder Shares to our Sponsor to cover for certain expenses on our behalf in exchange for the issuance of the 8,625,000 Founder Shares, and the loans entered into in the principal amount of up to $2,000,000 (the “March 2023 Loan”), in the principal amount of up to $1,700,000 (the “July 2023 Loan”), in the principal amount of up to $500,000 (the “November 2023 Loan”), in the principal amount of up to $1,250,000 (the “Second November 2023 Loan”), in the principal amount of up to $750,000 (the “April 2024 Loan”), and in the principal amount of up to $1,200,000 (the “June 2024 Loan,” and collectively, the “Loans”) with an affiliate of the Sponsor to provide the Company with additional working capital and to fund Extension Contributions into the Trust Account until the earlier of a completion of a Business Combination or the extended date of December 17, 2024.

For the six months ended June 30, 2024, we utilized $8,765,818 in operating activities, which was largely driven by $5,320,000 related to change in fair value on warrant liabilities, $2,685,613 in interest earned on Cash held in Trust Account, $2,546,926 in forgiveness of legal fees and $1,877,638 decrease in accounts payable and accrued expenses offset by $3,656,692 in net income and a $7,667 increase in prepaid expenses.

For the six months ended June 30, 2024, we were provided $23,692,454 in investing activities, which was driven by $750,000 in Extension Contributions and $24,442,454 in payments for redemptions.

For the six months ended June 30, 2024, we utilized $14,843,274 in financing activities, which was driven by $24,442,454 in payments made to shareholders for redemption, $1,700,000 in proceeds from Loans from the Sponsor and $7,899,180 in proceeds from a Loan from the Target.

For the six months ended June 30, 2023 we utilized $844,775 in operating activities, which was largely driven by $5,869,034 in net loss and $5,991,130 in interest earned on cash and investments held in Trust Account, offset by a $5,433,120 increase in accounts payable and accrued expense, a $5,264,750 loss on the change in value of our warrant liabilities and $317,519 in prepaid expenses.

For the six months ended June 30, 2023, we utilized $1,400,000 in our investing activities, which was driven entirely by Extension Contributions.

For the six months ended June 30, 2023, we were provided $2,000,000 in our financing activities, which was entirely the result of proceeds from our Loans.

The net proceeds from the sale of the Units in our IPO and the sale of the Private Placement Warrants for an aggregate purchase price of $16,700,000, after deducting offering expenses of $1,103,227 and underwriting commissions of $6,900,000 (excluding deferred underwriting commissions of $12,075,000), was $351,900,000, which is held in the Trust Account and includes the deferred underwriting commissions described above. The proceeds held in the Trust Account are invested in an interest-bearing account until the earlier of the consummation of our initial Business Combination or liquidation. Our shareholders have exercised their right of redemption in the amount of $268,092,426, which left $106,759,103 in proceeds and interest earned in the Trust Account as of June 30, 2024. As of July 31, 2024, a total of $107,149,176 was held in the Trust Account. This value reflects the approximately $24.4 million that was withdrawn for the redemptions that have occurred in the Third Extraordinary General Meeting.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (excluding deferred underwriting commissions) net of any redemptions, to complete our initial Business Combination. We may withdraw interest to pay our taxes, if any. Our annual income tax obligations will depend on the amount of interest and other income earned on the amounts held in the Trust Account. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

Prior to the completion of our initial Business Combination, as of June 30, 2024, we have available to us $182,038 of proceeds held outside the Trust Account, as well as any funds from loans from our Sponsor, its affiliates or members of our management team. We will use these funds to primarily identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

If our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $2,000,000 of such loans may be convertible into private placement warrants of the post Business Combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. Prior to the completion of our initial Business Combination, we do not expect to seek loans from parties other than our Sponsor or an affiliate of our Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account.

On March 7, 2023, we entered into a non-interest bearing convertible unsecured loan (the “March 2023 Loan”) in the principal amount of up to $2,000,000 from one of our Sponsor’s affiliates to provide us with additional working capital and to fund the initial Contributions described below. The portion of the March 2023 Loan used to provide us with additional working capital was not deposited into our Trust Account. If we do not consummate an initial Business Combination by the Extended Date, the March 2023 Loan will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The March 2023 Loan is convertible into private placement warrants of the post-Business Combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. The conversion option represents an embedded derivative under ASC 815-15, “Embedded Derivatives.” The Company has determined that based on the valuation of its Private Placement Warrants and the fact that a Business Combination is not considered probable until such time as it is consummated, the value of this conversion option is de minimis.

In addition, on July 6, 2023, November 15, 2023, November 27, 2023, April 15, 2024 and June 6, 2024, the Company entered into non-interest bearing unsecured loans in the principal amount of up to $1,700,000 (the “July 2023 Loan”), in the principal amount of up to $500,000 (the “November 2023 Loan”), in the principal amount of up to $1,250,000 (the “Second November 2023 Loan”), in the principal amount of up to $750,000 (“the April 2024 Loan”), and in the principal amount of up to $1,200,000 (the “June 2024 Loan,” together with the March 2023 Loan, the July 2023 Loan, the November 2023 Loan, the Second November 2023 Loan, and the April 2024 Loan, the “Loans”) with an affiliate of the Sponsor to fund Extension Contribution payments into the Trust Account until the earlier of a completion of the Business Combination of the Extended Date. The portion of the Loans used to provide the company with additional working capital are not deposited into the Trust Account.

The total amount outstanding under the Loans was $6,450,000 and $4,750,000 as of June 30, 2024 and December 31, 2023, respectively.

On March 14, 2023, we convened the First Extraordinary General Meeting virtually, at which our Sponsor agreed, by making monthly advancements on the March 2023 Loan, to contribute the Extension Contribution of lesser of (x) an aggregate of $350,000 or (y) $0.03 per share for each public share that was not redeemed at the First Extraordinary General Meeting for each monthly period (commencing on March 17, 2023 and ending on the 17th day of each subsequent month), or prior thereof, until the earlier of the completion of the initial Business Combination and the end of the Extension Period.

On December 5, 2023, we convened the Second Extraordinary General Meeting virtually, at which our Sponsor agreed, by making monthly advancements on the Loans, to contribute Extension Contributions into the Trust Account the lesser of (x) an aggregate of $150,000 or (y) $0.02 per share for each Public Share that was not redeemed at the Second Extraordinary General Meeting for each monthly period (commencing on December 17, 2023 and ending on the 17^th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial Business Combination and the Extended Date. For the avoidance of doubt, the maximum aggregate Extension contributions to the Trust Account shall not exceed $900,000 based on up to six monthly Extension Contributions through the Extended Date.

On May 21, 2024, the Company held an extraordinary general meeting (the “Third Extraordinary General Meeting”) to vote on a proposal to approve an Amendment to the Company’s Articles extending the date by which the Company must complete its initial Business Combination from June 17, 2024 to December 17, 2024 (the “Third Extension Amendment Proposal” and with respect to December 17, 2024, “the Extended Date”), and the shareholders approved the Third Extension Amendment Proposal at that meeting. In connection with the vote to approve the third Extension Amendment Proposal, the holders of 2,159,610 Class A ordinary shares properly exercised their rights to redeem their shares for cash at a redemption price of $11.32 per share. In connection with these redemptions, approximately $24.4 million was withdrawn from the Trust Account to fund such redemptions.

We expect our future primary liquidity requirements during the period until the Business Combination to include legal, accounting, due diligence, travel and other expenses associated with structuring, negotiating and documenting successful Business Combinations; legal and accounting fees related to regulatory reporting requirements; Nasdaq and other regulatory fees; consulting, travel and miscellaneous expenses incurred during the search for initial Business Combination target; and general working capital that will be used for miscellaneous expenses and reserves.

In addition, we could use a portion of the funds not being placed in trust to pay commitment fees for financing, fees to consultants to assist us with our search for a target business or as a down payment or to fund a “no-shop” provision (a provision designed to keep target businesses from “shopping” around for transactions with other companies or investors on terms more favorable to such target businesses) with respect to a particular proposed Business Combination, although we do not have any current intention to do so. If we entered into an agreement where we paid for the right to receive exclusivity from a target business, the amount that would be used as a down payment or to fund a “no-shop” provision would be determined based on the terms of the specific Business Combination and the amount of our available funds at the time. Our forfeiture of such funds (whether as a result of our breach or otherwise) could result in our not having sufficient funds to continue searching for, or conducting due diligence with respect to, prospective target businesses.

If we are not able to consummate our Business Combination before the end of the Business Combination Period, we will commence an automatic winding up, dissolution and liquidation. Management has determined that automatic liquidation, should a Business Combination not occur, and potential subsequent dissolution also raises substantial doubt about our ability to continue as a going concern. While management intends to complete a Business Combination, it is uncertain whether we will be able to do so. No adjustments have been made to the carrying amounts of assets or liabilities.

These conditions, including the working capital deficit and proximity to the end of our Extension Period, raise substantial doubt about our ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. There is no assurance that our plan to consummate a Business Combination will be successful within the Business Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Controls and Procedures

We are required to maintain an effective system of internal controls as defined by Section 404 of the Sarbanes-Oxley Act. Only in the event that we are deemed to be a large accelerated filer or an accelerated filer and no longer an emerging growth company would we be required to comply with the independent registered public accounting firm attestation requirement. Further, for as long as we remain an emerging growth company as defined in the JOBS Act, we intend to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirement.

We will assess the internal controls of our target business or businesses prior to the completion of our initial Business Combination and, if necessary, to implement and test additional controls as we may determine are necessary in order to state that we maintain an effective system of internal controls. A target business may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding the adequacy of internal controls. Many small and mid-sized target businesses we may consider for our initial Business Combination may have internal controls that need improvement in areas such as:

•

staffing for financial, accounting and external reporting areas, including segregation of duties;

•

reconciliation of accounts;

•

proper recording of expenses and liabilities in the period to which they relate;

•

evidence of internal review and approval of accounting transactions;

•

documentation of processes, assumptions and conclusions underlying significant estimates; and

•

documentation of accounting policies and procedures.

Because it will take time, management involvement and perhaps outside resources to determine what internal control improvements are necessary for us to meet regulatory requirements and market expectations for our operation of a target business, we may incur significant expenses in meeting our public reporting responsibilities, particularly in the areas of designing, enhancing, or remediating internal and disclosure controls. Doing so effectively may also take longer than we expect, thus increasing our exposure to financial fraud or erroneous financing reporting.

Off-Balance Sheet Arrangements

As of June 30, 2024, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

Commitments and Contractual Obligations

Registration Rights

Underwriting Agreement

The underwriter will be entitled to a deferred fee of $0.35 per Unit, or $12,075,000 in the aggregate with each entitled to $6,037,500. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Consulting Agreements

In June 2023, the Company entered into an agreement with a third-party consultant to provide advisory services in relation to the Business Combination. On July 15, 2024, the Company terminated the agreement with the third-party consultant and entered into a new agreement with the third-party consultant. As a result and as compensation for those services, an advisory fee of $3,000,000 is payable in the event the transaction is consummated (the “Advisory Fee”). This fee will only become payable in the event the Business Combination is consummated and as such nothing will be recorded until that time.

JOBS Act

The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an independent registered public accounting firm’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the report of the independent registered public accounting firm providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our IPO or until we are no longer an “emerging growth company,” whichever is earlier.

Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and income and expenses during the periods reported. Actual results could materially differ from those estimates. As of the end of the reporting period, we consider our critical accounting estimates to the fair value of our warrants and convertible promissory note.

Critical Accounting Policies

Management’s discussion and analysis of our results of operations and liquidity and capital resources are based on our financial statements. We describe our significant accounting policies in Note 2 – Summary of Significant Accounting Policies, of the Notes to Financial Statements included in this Report. Our financial statements have been prepared in accordance with U.S. GAAP. Certain of our accounting policies require that management apply significant judgments in defining the appropriate assumptions integral to financial estimates. On an ongoing basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with U.S. GAAP. Judgments are based on historical experience, terms of existing contracts, industry trends and information available from outside sources, as appropriate. However, by their nature, judgments are subject to an inherent degree of uncertainty, and, therefore, actual results could differ from our estimates.

Recent Accounting Standards

In August 2020, the FASB issued ASU No. 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”). The update simplifies the accounting for convertible instruments by removing certain separation models in Subtopic 470-20, Debt-Debt with Conversion and Other Options for convertible instruments and introducing other changes. As a result of ASU No. 2020-06, more convertible debt instruments will be accounted for as a single liability measured at amortized cost and more convertible preference shares will be accounted for as a single equity instrument measured at historical cost, as long as no features require bifurcation and recognition as derivatives. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU No. 2020-06 upon inception. The impact to the balance sheet, statements of operations and cash flows was not material.

In December 2023, the FASB issued ASU No 2023-09, “Income Taxes (Topic 7240) – Improvements to Income Tax Disclosures,” (“ASU 2023-09”) in order to enhance the transparency and usefulness of income tax disclosures. The guidance is applicable to all entities subject to income tax and it will require disclosure of certain categories within the rate reconciliation to improve consistency as well as disclosure of reconciling items which meet a certain quantitative threshold which will improve transparency. Additionally, entities must disclose the amount of taxes paid to federal, state and foreign municipalities. For public business entities ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The Company expects to adopt the standard for the fiscal year beginning January 1, 2025. The company is currently evaluating the impact of its pending adoption of ASU 2023-09 on its financial position, results of operations and financial statement disclosures.

We have considered all new accounting pronouncements and have concluded that there are no new pronouncements that may have a material impact on our results of operations, financial condition, or cash flows, based on the current information.

Factors That May Adversely Affect Our Results of Operations

Our results of operations and our ability to complete an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflicts in Ukraine and Gaza. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial Business Combination.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As of June 30, 2024, we were not subject to any material market or interest rate risk. Following the consummation of our IPO, the net proceeds of the IPO and the Private Placement, including amounts in the Trust Account, were invested in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act.

Prior to December 14, 2023, funds in the Trust Account were held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. However, to mitigate the risk of the Company being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment company Act), prior to the 24-month anniversary of the Effective Date of the registration statement relating to the Company’s IPO, the company instructed Continental to liquidate the U.S. government treasury obligations or money market funds held in the Trust

Account and to hold all funds in the Trust Account in cash in an interest bearing account until the earlier of consummation of its initial Business Combination or liquidation. In connection with such instructions, on December 14, 2023, the company and Continental entered into an amendment to the Trust Agreement, which governs the investment of monies held in the Trust Account, to specifically allow the investment of those funds into an interest-bearing account.

Due to the short-term nature of these investments, we believe there was no associated material exposure to interest rate risk.

We have not engaged in any hedging activities since our inception. We do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this quarterly report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our principal executive officer and principal financial and accounting officer (our “Certifying Officers”) evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2024, pursuant to Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of June 30, 2024, our disclosure controls and procedures were not effective due to material weaknesses in our internal control over financial reporting in connection with lack of controls to assure the accuracy and completeness of accrued expenses, classification and presentation of forgiveness of accrued legal expenses as other income and interest earned in the Trust Account.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Specifically, we concluded that our controls over recognition of accrued expenses were not effectively designed of maintained. Our management performance additional analysis as deemed necessary to ensure that our financial statements included in this Quarterly Report on Form 10-Q were prepared in accordance with generally accepted accounting practices in the United States. Accordingly, management believes that the financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material respects, our financial position, results of operations and cash flows of the periods presented.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management team, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

In light of the material weakness described above our management team has performed additional accounting and financial analyses and other post-closing procedures. We have enhanced, and will continue to enhance, our internal controls and procedures. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we plan to continue to improve these processes to ensure that the nuances of such transactions are effectively evaluated.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Management’s Report on Internal Controls Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control-Integrated Framework (2013), our management concluded that our internal control over financial reporting were not effective as of June 30, 2024.

In light of the material weakness described above, our management team has performed additional accounting and financial analyses and other post-closing procedures. We have enhanced, and will continue to enhance, internal controls and procedures. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant of unusual transactions, we plan to continue to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II-OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

Factors that could cause our actual results to differ materially from those in this report include the risks described under the heading “Risk Factors” included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the SEC on April 11, 2024 (the “2023 10-K”). Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Report, there have been no material changes to the risk factors disclosed in the 2023 10-K. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

No underwriting discounts or commissions were paid with respect to such sales.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits


No.		Description of Exhibit

10.1		Loan Agreement (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K filed with the SEC on June 10, 2024).

31.1*		Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*		Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		Inline XBRL Instance Document

101.SCH		Inline XBRL Taxonomy Extension Schema Document

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		Inline XBRL Taxonomy Extension Definitions Linkbase Document

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

*	Filed herewith

**	Furnished herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) OR 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Baroness Ruby McGregor-Smith, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 of Investcorp Europe Acquisition Corp I.

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) OR 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Craig Sinfield-Hain, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 of Investcorp Europe Acquisition Corp I.

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Investcorp Europe Acquisition Corp I (the “Company”) on Form 10-Q for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission (the “Report”), I, Baroness Ruby McGregor-Smith, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as added by § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

*	The foregoing certification is being furnished solely pursuant to 18 U.S.C. §1350 and is not being filed as part of the Report or as a separate disclosure document.

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Investcorp Europe Acquisition Corp I (the “Company”) on Form 10-Q for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission (the “Report”), I, Craig Sinfield-Hain, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as added by § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

*	The foregoing certification is being furnished solely pursuant to 18 U.S.C. §1350 and is not being filed as part of the Report or as a separate disclosure document.

Cover Page - shares	6 Months Ended
Cover Page - shares	Jun. 30, 2024	Aug. 16, 2024
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity Registrant Name	Investcorp Europe Acquisition Corp I
Entity Central Index Key	0001857410
Entity File Number	001-41161
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	Century Yard
Entity Address, Address Line Two	Cricket Square Elgin Avenue
Entity Address, Address Line Three	P.O. Box 1111
Entity Address, City or Town	George Town
Entity Address, Country	KY
Entity Address, Postal Zip Code	KY1-1102
City Area Code	345
Local Phone Number	949-5122
Document Quarterly Report	true
Document Transition Report	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	true
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	IVCB
Security Exchange Name	NASDAQ
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
Trading Symbol	IVCBU
Security Exchange Name	NASDAQ
Redeemable warrants [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	IVCBW
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		18,010,684
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1

Condensed Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current Assets
Cash	$ 182,038	$ 98,676
Prepaid expenses	68,572	76,239
Interest receivable	0	62,706
Total Current Assets	250,610	237,621
Cash held in Trust Account	106,759,103	127,703,238
Total Assets	107,009,713	127,940,859
Current liabilities
Accounts payable and accrued expenses	4,225,970	8,650,534
Note Payable to Sponsor	6,450,000	4,750,000
Note Payable to Target	7,899,180	0
Total Current Liabilities	18,575,150	13,400,534
Warrant liabilities	2,462,000	7,782,000
Deferred underwriting fee payable	6,037,500	12,075,000
Total Liabilities	27,074,650	33,257,534
Commitments and Contingencies
Shareholders' Deficit
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at June 30, 2024 and December 31, 2023	0	0
Accumulated deficit	(26,824,903)	(33,083,482)
Total Shareholders' Deficit	(26,824,040)	(33,082,619)
Total Liabilities, Shares Subject to Redemption and Shareholders' Deficit	107,009,713	127,940,859
Common Class A [Member]
Current liabilities
Class A ordinary shares subject to possible redemption, $0.0001 par value; 9,385,685 and 11,545,295 shares at $11.37 and $11.07 per share redemption value at June 30, 2024 and December 31, 2023, respectively	106,759,103	127,765,944
Shareholders' Deficit
Common Stock	863	863
Common Class B [Member]
Shareholders' Deficit
Common Stock	$ 0	$ 0

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Class A [Member]
Temporary Equity, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Temporary Equity, Shares Outstanding	9,385,685	11,545,295
Temporary Equity, Redemption Price Per Share	$ 11.37	$ 11.07
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	400,000,000	400,000,000
Common Stock, Shares, Issued	8,624,999	8,624,999
Common Stock, Shares, Outstanding	8,624,999	8,624,999
Common Class B [Member]
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	40,000,000	40,000,000
Common Stock, Shares, Issued	1	1
Common Stock, Shares, Outstanding	1	1

Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
Condensed Statements of Operations - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Formation and operating costs	$ 3,355,845	$ 2,885,101	$ 6,796,667	$ 6,595,415
Loss from Operations	(3,355,845)	(2,885,101)	(6,796,667)	(6,595,415)
Other income (expense)
Change in fair value of warrant liabilities	(1,273,750)	(3,249,935)	5,320,000	(5,264,750)
Interest earned on Cash and Investments held in Trust Account	1,282,016	2,382,313	2,685,613	5,991,131
Forgiveness of legal fees	2,546,926	0	2,546,926	0
Interest expense	(99,180)	0	(99,180)	0
Total other income (expense)	2,456,012	(867,622)	10,453,359	726,381
Net Income (Loss)	$ (899,833)	$ (3,752,723)	$ 3,656,692	$ (5,869,034)
Redeemable Class A ordinary shares [Member]
Other income (expense)
Basic weighted average shares outstanding	10,572,284	19,005,667	11,058,789	24,826,742
Basic net income (loss) per share, Basic	$ (0.05)	$ (0.14)	$ 0.19	$ (0.18)
Diluted weighted average shares outstanding	10,572,284	19,005,667	11,058,789	24,826,742
Diluted net income (loss) per share, Diluted	$ (0.05)	$ (0.14)	$ 0.19	$ (0.18)
Non-Redeemable ordinary shares [Member]
Other income (expense)
Basic weighted average shares outstanding	8,625,000	8,625,000	8,625,000	8,625,000
Basic net income (loss) per share, Basic	$ (0.05)	$ (0.14)	$ 0.19	$ (0.18)
Diluted weighted average shares outstanding	8,625,000	8,625,000	8,625,000	8,625,000
Diluted net income (loss) per share, Diluted	$ (0.05)	$ (0.14)	$ 0.19	$ (0.18)

Condensed Statements of Changes in Shareholders' Deficit - USD ($)	Total	Accumulated Deficit [Member]	Common Class A [Member] Ordinary Shares [Member]	Common Class B [Member] Ordinary Shares [Member]
Beginning balance (in shares) at Dec. 31, 2022				8,625,000
Beginning balance at Dec. 31, 2022	$ (13,842,830)	$ (13,843,693)		$ 863
Extension Contribution	(350,000)	(350,000)
Remeasurement of redeemable shares to redemption value	(3,608,818)	(3,608,818)
Net income (loss)	(2,116,311)	(2,116,311)
Ending balance at Mar. 31, 2023	(19,917,959)	(19,918,822)		$ 863
Ending balance (in shares) at Mar. 31, 2023				8,625,000
Beginning balance (in shares) at Dec. 31, 2022				8,625,000
Beginning balance at Dec. 31, 2022	(13,842,830)	(13,843,693)		$ 863
Deferred underwriters' fee commission waiver	0
Remeasurement of redeemable shares to redemption value	5,991,131
Net income (loss)	(5,869,034)
Ending balance at Jun. 30, 2023	(27,102,995)	(27,103,858)		$ 863
Ending balance (in shares) at Jun. 30, 2023				8,625,000
Beginning balance (in shares) at Mar. 31, 2023				8,625,000
Beginning balance at Mar. 31, 2023	(19,917,959)	(19,918,822)		$ 863
Extension Contribution	(1,050,000)	(1,050,000)
Remeasurement of redeemable shares to redemption value	(2,382,313)	(2,382,313)
Net income (loss)	(3,752,723)	(3,752,723)
Ending balance at Jun. 30, 2023	(27,102,995)	(27,103,858)		$ 863
Ending balance (in shares) at Jun. 30, 2023				8,625,000
Beginning balance (in shares) at Dec. 31, 2023			8,624,999	1
Beginning balance at Dec. 31, 2023	(33,082,619)	(33,083,482)	$ 863
Extension Contribution	(450,000)	(450,000)
Remeasurement of redeemable shares to redemption value	(1,403,597)	(1,403,597)
Net income (loss)	4,556,525	4,556,525
Ending balance at Mar. 31, 2024	(30,379,691)	(30,380,554)	$ 863
Ending balance (in shares) at Mar. 31, 2024			8,624,999	1
Beginning balance (in shares) at Dec. 31, 2023			8,624,999	1
Beginning balance at Dec. 31, 2023	(33,082,619)	(33,083,482)	$ 863
Deferred underwriters' fee commission waiver	6,037,500
Remeasurement of redeemable shares to redemption value	2,685,613
Net income (loss)	3,656,692
Ending balance at Jun. 30, 2024	(26,824,040)	(26,824,903)	$ 863
Ending balance (in shares) at Jun. 30, 2024			8,624,999	1
Beginning balance (in shares) at Mar. 31, 2024			8,624,999	1
Beginning balance at Mar. 31, 2024	(30,379,691)	(30,380,554)	$ 863
Deferred underwriters' fee commission waiver	6,037,500	6,037,500
Extension Contribution	(300,000)	(300,000)
Remeasurement of redeemable shares to redemption value	(1,282,016)	(1,282,016)
Net income (loss)	(899,833)	(899,833)
Ending balance at Jun. 30, 2024	$ (26,824,040)	$ (26,824,903)	$ 863
Ending balance (in shares) at Jun. 30, 2024			8,624,999	1

Condensed Statements of Cash Flows - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended	18 Months Ended
Condensed Statements of Cash Flows - USD ($)	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Jun. 30, 2024
Cash Flows from Operating Activities:
Net income (loss)	$ (899,833)	$ 4,556,525	$ (3,752,723)	$ (2,116,311)	$ 3,656,692	$ (5,869,034)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on Cash and Investments held in Trust Account	(1,282,016)		(2,382,313)		(2,685,613)	(5,991,131)
Forgiveness of legal fee					(2,546,926)	0
Change in fair value of warrant liabilities	1,273,750		3,249,935		(5,320,000)	5,264,750
Changes in operating assets and liabilities:
Prepaid expenses					7,667	317,519
Accounts payable and accrued expenses					(1,877,638)	5,433,121
Net cash used in operating activities					(8,765,818)	(844,775)
Cash Flows from Investing Activities:
Extension Contribution					(750,000)	(1,400,000)		$ (4,050,000)
Withdrawal from Trust Account for redemptions					24,442,454	0
Net cash provided by (used in) investing activities					23,692,454	(1,400,000)
Cash Flows from Financing Activities:
Proceeds from affiliate promissory note					1,700,000	2,000,000
Proceeds from target promissory note					7,899,180	0
Redemptions paid out					(24,442,454)	0
Net cash (used in) provided by financing activities					(14,843,274)	2,000,000
Net change in cash					83,362	(244,775)
Cash at beginning of period		98,676		479,009	98,676	479,009	$ 479,009	479,009
Cash at end of period	182,038		234,234		182,038	234,234	$ 98,676	$ 182,038
Supplemental disclosure of cash flow information:
Remeasurement of redeemable shares to redemption value	(1,282,016)	$ (1,403,597)	$ (2,382,313)	$ (3,608,818)	2,685,613	5,991,131
Deferred underwriters' fee commission waiver	$ 6,037,500				$ 6,037,500	$ 0

Organization and Business Operation	6 Months Ended
Organization and Business Operation	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business Operation	Note 1—Organization and Business Operation Investcorp Asia Acquisition Corp I was incorporated in the Cayman Islands on March 22, 2021 . On October 7, 2021, the Company changed its name to Investcorp Europe Acquisition Corp I (the “Company”). The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or assets (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of June 30, 2024, the Company had not commenced any operations. All activity for the period from March 22, 2021 (inception) through June 30, 2024 relates to the Company’s formation and Initial Public Offering of units (the “IPO”) described below, and since the IPO, the search for a target business. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company expects to generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds expected to be derived from the IPO. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s IPO was declared effective on December 14, 2021 (the “Effective Date”). On December 17, 2021, the Company consummated its IPO of 34,500,000 units, which included the full exercise of the underwriters’ over-allotment option of 4,500,000 units (the “Units” and, with respect to the ordinary shares included in the Units offered, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $345,000,000, which is discussed further in Note 3. Simultaneously with the closing of the IPO, the Company consummated the sale of 16,700,000 warrants (the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant in a private placement to Europe Acquisition Holdings Limited (the “Sponsor”), generating proceeds of $16,700,000. Following the closing of the IPO on December 17, 2021, $351,900,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account (“Trust Account”), located in the United States at a nationally recognized financial institution, with Continental Stock Transfer & Trust Company (“Continental”) acting as trustee. Prior to December 14, 2023, funds in the Trust Account were held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940 (the “Investment Company Act”). However, to mitigate the risk of the Company being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), prior to the 24-month anniversary of the Effective Date of the registration statement relating to the Company’s IPO, the Company instructed Continental to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and to hold all funds in the Trust Account in cash in an interest bearing account until the earlier of consummation of its initial Business Combination or liquidation. In connection with such instructions, on December 14, 2023, the Company and Continental entered into an amendment to the Investment Management Trust Agreement dated December 11, 2021 (the “Trust Agreement”), which governs the investment of monies held in the Trust Account, to specifically allow the investment of those funds into an interest-bearing account. Pursuant to the Trust Agreement, the trustee is not permitted to invest in other securities or assets. The Trust Account is intended as a holding place for funds pending the earliest to occur of either: (i) the completion of the initial Business Combination; (ii) the redemption of any Public Shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (the “Articles”) to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete the initial Business Combination within the time frame to consummate the business combination period (the “Business Combination Period”) as defined in its Articles or during any extended time that the Company has to consummate a Business Combination as a result of a shareholder vote to amend its Articles (an “Extension Period”) or (B) with respect to any other provision relating to shareholders’ rights or pre-Business Combination activity; and (iii) absent an initial Business Combination within the Business Combination Period or Extension Period from the closing of the IPO, the return of the funds held in the Trust Account to the Company’s public shareholders as part of the redemption of the Public Shares. If the Company has not consummated the initial Business Combination within the required time period, the public shareholders may receive only approximately $10.20 per Public Share, or less in certain circumstances, on the liquidation of the Trust Account and the warrants will expire worthless. If the Company seeks shareholder approval to proceed with a Business Combination, a majority of the shares voted in favor of the Business Combination would be required. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Articles, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the IPO in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or don’t vote at all. Notwithstanding the above, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Articles provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Extension Period and (c) not to propose an amendment to the Articles (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Extension Period. However, if the Sponsor acquires Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Extension Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 11) held in the Trust Account in the event the Company does not complete a Business Combination within the Extension Period; and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than $10.20 per Public Share. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.20 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.20 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Extraordinary General Meetings On March 14, 2023, the Company convened an extraordinary general meeting (the “First Extraordinary General Meeting”) virtually, to vote on the proposals described below. A total of 34,372,929 of the Company’s Class A ordinary shares and Class B ordinary shares (the “Ordinary Shares”), or 79.1% of the Company’s outstanding shares as of February 22, 2023, the record date for the First Extraordinary General Meeting, were represented virtually or by proxy at the First Extraordinary General Meeting. As approved by its shareholders at the First Extraordinary Meeting, the Company filed an amendment (the “First Extension Amendment”), which (i) extended the date by which the Company must consummate its initial Business Combination from March 17, 2023 to December 17, 2023 and (ii) removed the limitation that the Company shall not redeem public shares to the extent that such redemption would cause the Company’s net tangible assets to be less than $5,000,001 (the “Redemption Limitation Amendment”). Additionally, at the First Extraordinary General Meeting holders of Public Shares were afforded the opportunity to require the Company to redeem their Public Shares for their pro rata share of the Trust Account. In connection with the vote to approve the First Extension Amendment and the Redemption Limitation Amendment, the holders of 15,494,333 Class A ordinary shares properly exercised their rights to redeem their shares for cash at a redemption price of approximately $10.43 per share for an aggregate redemption amount of approximately $161.6 million, leaving 19,005,667 Public Shares remaining outstanding. Following this redemption, the balance in the Trust Account was approximately $198.2 million. In connection with the approval of the First Extension Amendment, the Sponsor had agreed, by making monthly advancements on the March 2023 Loan (as defined below), to contribute (each such contribution, an “Extension Contribution”) into the Trust Account the lesser of (x) an aggregate of $350,000 or (y) $0.03 per share for each public share that was not redeemed at the First Extraordinary General Meeting for each monthly period (commencing on March 17, 2023 and ending on the 17 th day of each subsequent month), or prior thereof, until the earlier of the completion of the initial Business Combination and December 17, 2023. On December 5, 2023, the Company held an extraordinary general meeting (the “Second Extraordinary General Meeting”), at which holders of Public Shares approved an amendment to the Articles to extend the date by which the Company must complete its initial Business Combination from December 17, 2023 to June 17, 2024. As a result of the approval of the extension to June 17, 2024, the Sponsor agreed, by making monthly advancements on the Loans (as defined below), to make Extension Contributions into the Trust Account in the amount of the lesser of (x) an aggregate of $150,000 or (y) $0.02 per share for each Class A ordinary share included as part of the Units sold in the Company’s IPO (including any shares issued in exchange thereof) that were not redeemed at the Second Extraordinary General Meeting for each monthly period (commencing on December 17, 2023 and ending on the 17th day of each subsequent month), or portion thereof, until the earlier of the completion of the initial Business Combination and June 17, 2024. Additionally, at the Second Extraordinary General Meeting holders of Public Shares were afforded the opportunity to require the Company to redeem their Public Shares for their pro rata share of the Trust Account. The holders of 7,460,372 Class A ordinary shares properly exercised their rights to redeem their shares for cash at a redemption price of approximately $11.00 per share for an aggregate redemption amount of approximately $82.0 million, leaving 11,545,295 Public Shares remaining outstanding. On May 21, 2024, the Company held an extraordinary general meeting (the “Third Extraordinary General Meeting”) to vote on a proposal to approve an Amendment to the Company’s Articles extending the date by which the Company must complete its initial Business Combination from June 17, 2024 to December 17, 2024 (the “Third Extension Amendment Proposal” and with respect to December 17, 2024, the “Extended Date”), and the stockholders approved the Third Extension Amendment Proposal at that meeting. In connection with the vote to approve the Third Extension Amendment Proposal, the holders of 2,159,610 Class A ordinary shares properly exercised their rights to redeem their shares for cash at a redemption price of $11.32 per share. In connection with this redemption, approximately $24.4 million was withdrawn from the Trust Account to fund such redemptions. As of June 30, 2024, the Company had made nine Extension Contribution payments pursuant to the March 2023 Loan, the July 2023 Loan and the November 2023 Loan (as defined below), each in the amount of $350,000, as well as six Extension Contribution Payments pursuant to the Second November 2023 Loan and the April 2024 Loan, each in the amount of $150,000. For a more detailed description of the Loans, see “Liquidity, Capital Resources and Going Concern.” In connection with the Third Extension, the Company ceased making Extension Contributions on June 17, 2024. Liquidity, Capital Resources and Going Concern As of June 30, 2024, the Company had $182,038 in its operating bank accounts and working capital deficit of $18,324,540. As of June 30, 2024, approximately $6,975,116 of the amount on deposit in cash held in the Trust Account represented interest income and $4,050,000 represented an Extension Contribution, all of which are available to pay the Company’s tax obligations, if any. The Company’s liquidity needs up to December 17, 2021 had been satisfied through a payment from the Sponsor of $25,000 (see Note 6) for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of up to $300,000. In addition, in order to finance transaction costs in connection with the Business Combination, the Company’s Sponsor, an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 6). As of June 30, 2024, there were no amounts outstanding under any Working Capital Loans. On March 7, 2023, the Company entered into a non-interest bearing convertible unsecured loan (the “March 2023 Loan”) in the principal amount of up to $2,000,000 from one of the Sponsor’s affiliates to provide the Company with additional working capital and to fund the Extension Contributions. The portion of the March 2023 Loan used to provide the Company with additional working capital was not deposited into the Trust Account. If the Company does not consummate an initial Business Combination by the Extension Period, the March 2023 Loan will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The March 2023 Loan is convertible into Private Placement Warrants of the post-Business Combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. The conversion option represents an embedded derivative under ASC 815-15, “Embedded Derivatives.” The Company has determined that based on the valuation of its Private Placement Warrants and the fact that a Business Combination is not considered probable until such time as it is consummated, the value of this conversion option is de minimis. In addition, on July 6, 2023, November 15, 2023, November 27, 2023, April 15, 2024 and June 6, 2024, the Company entered into non-interest bearing unsecured loans in the principal amount of up to $1,700,000 (the “July 2023 Loan”), in the principal amount of up to $500,000 (the “November 2023 Loan”), in the principal amount of up to $1,250,000 (the “Second November 2023 Loan”), in the principal amount of up to $750,000 (the “April 2024 Loan”), and in the principal amount of up to $1,200,000 (the “June 2024 Loan” and, together with the March 2023 Loan, the July 2023 Loan, the November 2023 Loan, the Second November 2023 Loan and the April 2024 Loan, the “Loans”) with an affiliate of the Sponsor to provide the Company with additional working capital and to fund Extension Contributions into the Trust Account until the earlier of a completion of the Business Combination or the Extended Date. The July 2023 Loan, the November 2023 Loan, the Second November 2023 Loan, the April 2024 Loan and the June 2024 Loan bear no interest and shall be due and payable on the earlier of (i) the date on which the Company consummates a Business Combination or (ii) the date of that the winding up of the Company is effective. If the Company does not consummate an initial Business Combination by the Extended Date, the July 2023 Loan, the November 2023 Loan, the Second November 2023 Loan, the April 2024 Loan and the June 2024 Loan will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. If at any time the board of directors of the Company determines that the Company will not be able to consummate an initial Business Combination by the Extended Date and that the Company shall instead liquidate, the Sponsor’s obligation to continue to make the Extension Contributions shall cease immediately upon such determination. The total amount outstanding under the Loans entered into on March 7, 2023, July 6, 2023, November 15, 2023, November 27, 2023, April 15, 2024, June 6, 2024 and any other Working Capital Loans as of June 30, 2024 and December 31, 2023 was $6,450,000 and $4,750,000, respectively. If the Company is not able to consummate a Business Combination before the end of the Extension Period, the Company will commence an automatic winding up, dissolution and liquidation. Management has determined that automatic liquidation, should a Business Combination not occur, and potential subsequent dissolution also raises substantial doubt about the Company’s ability to continue as a going concern. While management intends to complete a Business Combination, it is uncertain whether the Company will be able to do so. No adjustments have been made to the carrying amounts of assets or liabilities. Under Accounting Standards Update (ASU) 2014-15, “Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”), these conditions, including the working capital deficit as well as the remaining time in the Extension Period, raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. There is no assurance that the Company’s plan to consummate a Business Combination will be successful within the Extension Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Significant Accounting Policies

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Significant Accounting Policies

Note 2—Significant Accounting Policies

Basis of Presentation

10-Q

and Article 8 of Regulation

S-X

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form

10-K

10-

K for the year ended December 31, 2023, as filed with the SEC on April 11, 2024.

Emerging Growth Company Status

non-emerging

Use of Estimates

Cash and Cash Equivalents

Cash Held in Trust Account

Concentration of Credit Risk

Offering Costs Associated with Initial Public Offering

The Company complies with the requirements of the ASC

340-10-S99-1

one-half

Net Income (Loss) Per Ordinary Share

The Company’s statements of operations include a presentation of net income (loss) per share for Ordinary Shares subject to possible redemption and applies the

two-class

method in calculating net income (loss) per share. Net income (loss) per Ordinary Share, basic and diluted, is calculated by dividing the

pro-

rata allocation of net income (loss) for each class, by the weighted average number of Class A and Class B

non-redeemable

Ordinary Shares outstanding for the period. Net income (loss) is allocated

pro-rata

between Class A redeemable and Class B

non-redeemable

The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):


	For the three months ended
	June 30, 2024						June 30, 2023
	Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares			Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares
Basic and diluted net loss per share:
Numerator:
Allocation of net loss	$	(495,554	)	$	(404,279	)	$	(2,581,299	)	$	(1,171,424	)

Denominator:
Weighted-average shares outstanding		10,572,284			8,625,000			19,005,667			8,625,000

Basic and diluted net loss per share	$	(0.05	)	$	(0.05	)	$	(0.14	)	$	(0.14	)


	For the six months ended
	June 30, 2024				June 30, 2023
	Redeemable Class A Ordinary Shares		Non- Redeemable Ordinary Shares		Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares
Basic and diluted net (loss) income per share:
Numerator:
Allocation of net (loss) income	$	2,054,411	$	1,602,281	$	(4,355,797	)	$	(1,513,237	)

Denominator:
Weighted-average shares outstanding		11,058,789		8,625,000		24,826,742			8,625,000

Basic and diluted net (loss) income per share	$	0.19	$	0.19	$	(0.18	)	$	(0.18	)

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Fair Value Measurements

Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

Derivative Financial Instruments

then re-valued at

or non-current based

on whether or

not net-cash settlement

or conversion of the instrument could be required within 12 months of the balance sheet date.

to re-measurement at

as non-current liabilities

as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Ordinary Shares Subject to Possible Redemption

additional paid-in capital

and accumulated deficit.

As of June 30, 2024 and December 31, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:


	June 30, 2024			December 31, 2023
As of beginning of the period	$	127,765,944		$	356,976,644
Less:
Redemptions as a result of Extraordinary General Meeting		(24,442,454	)		(243,649,972	)
Plus:
Extension Contribution		750,000			3,300,000
Remeasurement of carrying value to redemption value		2,685,613			11,139,272

Class A ordinary shares subject to possible redemption	$	106,759,103		$	127,765,944

Income taxes

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU

No. 2020-06,

“Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU

2020-06”).

The update simplifies the accounting for convertible instruments by removing certain separation models in Subtopic

470-20,

Debt—Debt with Conversion and Other Options for convertible instruments and introducing other changes. As a result of ASU

No. 2020-06,

No. 2020-06

upon its inception. The impact to the balance sheet, statements of operations and cash flows was not material.

In December 2023, the FASB issued ASU No

2023-09,

“Income Taxes (Topic 740)—Improvements to Income Tax Disclosures” (“ASU

2023-09”)

2023-09

on its financial position, results of operations or financial statement disclosure.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering	6 Months Ended
Initial Public Offering	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Initial Public Offering	Note 3— Initial Public Offering On December 17, 2021 the Company sold 34,500,000 Units, which included 4,500,000 Units from the underwriters’ full exercise of their over-allotment option, at a price of $10.00 per Unit, generating gross proceeds to the Company of $345,000,000. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 10). Following the closing of the IPO on December 17, 2021 an aggregate of $351,900,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into the Trust Account. Prior to December 14, 2023, funds in the Trust Account were held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. However, to mitigate the risk of the Company being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), prior to the 24-month anniversary of the Effective Date of the registration statement relating to the Company’s IPO, the Company instructed Continental to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and to hold all funds in the Trust Account in cash in an interest bearing account until the earlier of consummation of its initial Business Combination or liquidation. In connection with such instructions, on December 14, 2023, the Company and Continental entered into an amendment to the Trust Agreement to specifically allow the investment of those funds into an interest-bearing account. Transaction costs of the IPO amounted to $20,078,227 consisting of $6,900,000 of underwriting fee, $12,075,000 of deferred underwriting fee and $1,103,227 of other offering costs. Of the transaction costs, $19,224,170 was included in additional paid-in capital and $854,057 was included in accumulated deficit.

Signed Business Combination Agreement

6 Months Ended

Jun. 30, 2024

Business Combinations [Abstract]

Signed Business Combination Agreement

Note 4— Signed Business Combination Agreement

Original Business Agreement

one-half

of a Warrant, which underlying securities shall be converted as set forth below and in accordance with the terms and conditions of the Business Combination Agreement.

At the Second Merger Effective Time, by virtue of the Second Merger and without any further action required on the part of any Party or the holders of securities of the Company or Merger Sub II:

(1)

Class

A ordinar

: Each Class A ordinary share issued and outstanding immediately prior to the Second Merger Effective Time (after giving effect to redemptions) shall be exchanged for one Pubco Ordinary Share.

(2)

Warrants

(1)

(2)

if at any time from the Second Merger Effective Time through the date that is the tenth anniversary of the Second Merger Effective Time there is a change of control of Pubco.

In connection with the Business Combination Agreement, the Company entered into the following agreements:

Backstop Agreement:

Insider Letter Amendment:

Sponsor Support Agreement:

In connection with the Closing, the Company will enter into, among others, the following agreements:

Lock-Up

Agreement:

At the Share Contribution Closing, the Orca Shareholders and Pubco shall enter into a

lock-up

Registration Rights Agreement:

Warrant Assignment, Assumption and Amendment:

10A-3

of the Exchange Act, with three individuals designated by Orca, two individuals designated by the Company and two individuals appointed jointly by Orca and the Company.

CA-MC

Divestiture Proceeds

Divestiture Transition Matters

Fairness Opinion

Representations and Warranties; Covenants

Termination

Proceeds Advance

Conversion of Class B Ordinary Shares

The Second BCA Amendment provides for the conversion of the Class B ordinary shares into Class A ordinary shares, which was elected on December 22, 2023 and effected on January 2, 2024.

Subscription Agreement

Pursuant to the Subscription Agreement, Pubco has granted the Subscriber customary registration rights, on the terms and subject to the conditions set forth therein.

At the Closing, Pubco and the Subscriber will enter into a

lock-up

Private Placement Warrants	6 Months Ended
Private Placement Warrants	Jun. 30, 2024
Private Placement Warrants [Abstract]
Private Placement Warrants	Note 5—Private Placement Warrants Simultaneously with consummation of the IPO, the Sponsor purchased an aggregate of 16,700,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant ($16,700,000 in the aggregate). Each whole Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Extension Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.

Related Party Transactions	6 Months Ended
Related Party Transactions	Jun. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Note 6—Related Party Transactions Founder Shares On April 1, 2021, the Sponsor purchased 8,625,000 shares of the Company’s Class B ordinary shares (the “Founder Shares”) for an aggregate purchase price of $25,000. On November 3, 2021, the Sponsor transferred 718,750 Founder Shares to Baroness Ruby McGregor-Smith, 479,167 Founder Shares to Peter McKellar, and 30,000 Founder Shares to each of Pam Jackson, Laurence Ponchaut and Adah Almutairi, at approximately $0.12 per share. On December 14, 2021, in connection with the increase in the size of the IPO, the Company effected a capitalization increasing the number of Founder Shares held by each initial shareholder by 20%, thereby increasing the aggregate number of issued and outstanding Founder Shares to 8,625,000. This resulted in a benefit to the Company from the excess fair value of shares issued over the nominal purchase price. The excess fair value of the Founder Shares over their nominal purchase price is estimated to be $5,292,600 and will be recorded as compensation expense upon closing of the Business Combination. The Sponsor and the Company’s directors and executive officers have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary share equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 120 days after a Business Combination, or (y) if the Company consummates a transaction after the initial Business Combination which results in shareholders having the right to exchange their shares for cash, securities or other property. On December 22, 2023, and effected on January 2, 2024, the Sponsor and certain directors and officers of the Company voluntarily elected to convert an aggregate 8,624,999 Class B ordinary shares to Class A ordinary shares, par value $0.0001 per share, of the Company, on a one-for-one basis in accordance with the Articles. Following this conversion, there was 1 Class B ordinary share outstanding and 8,624,999 Class A ordinary shares that are non-redeemable. Related Party Loans In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor may, but is not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. At the lender’s discretion, up to $2,000,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The terms of the warrants would be identical to the terms of the Private Placement Warrants. On March 7, 2023, the Company entered into a non-interest bearing convertible unsecured loan (the “March 2023 Loan”) in the principal amount of up to $2,000,000 from one of the Sponsor’s affiliates to provide the Company with additional working capital and to fund the Extension Contributions. The March 2023 Loan constitutes a Working Capital Loan as defined above. The portion of the Loan used to provide the Company with additional working capital was not deposited into the Trust Account. If the Company does not consummate an initial Business Combination during the Extension Period, the March 2023 Loan will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The March 2023 Loan is convertible into private placement warrants of the post-Business Combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. The conversion option represents an embedded derivative under ASC 815-15, “Embedded Derivatives.” The Company has determined that based on the valuation of its Private Placement Warrants and the fact that a Business Combination is not considered probable until such time as it is consummated, the value of this conversion option is de minimis. In addition, on July 6, 2023, November 15, 2023, November 27, 2023, April 15, 2024 and June 6, 2024, the Company entered into non-interest bearing unsecured loans in the principal amount of up to $1,700,000 (the “July 2023 Loan”), in the principal amount of up to $500,000 (the “November 2023 Loan”), in the principal amount of up to $1,250,000 (the “Second November 2023 Loan”), in the principal amount of up to $750,000 (the “April 2024 Loan”), and in the principal amount of up to $1,200,000 (the “June 2024 Loan,” together with the March 2023 Loan, the July 2023 Loan, the November 2023 Loan, the Second November 2023 Loan, and the April 2024 the “Loans”) with an affiliate of the Sponsor to provide the Company with additional working capital and to fund monthly Extension Contribution payments into the Trust Account until the earlier of a completion of the Business Combination or the Extended Date. The portion of the Loans used to provide the Company with additional working capital are not deposited into the Trust Account. The total amount outstanding under the Loans entered into described above as of June 30, 2024 was $6,450,000, of which $4,050,000 was utilized as Extension Contributions. As of December 31, 2023, there was $4,750,000 outstanding under the Loans, of which $3,300,000 was utilized as Extension Contributions.

Loan Payable to Target	6 Months Ended
Loan Payable to Target	Jun. 30, 2024
Payables and Accruals [Abstract]
Loans Payable To Target Disclosure [Text Block]	Note 7—Loan Payable to Target On May 3, 2024, in connection with the Third Amendment to the Business Combination Agreement, the Divestiture Escrow Account paid $7.8 million to the Company’s legal advisor as settlement of renegotiated fees incurred through that time (See Note 11). The $7.8 million represented the Specified Transaction Expenses contemplated in the Third Amendment to the Business Combination Agreement. In the event that the Business Combination is not consummated, these fees would be due back to the Divestiture Escrow Account with interest of 8% per annum. As the Business Combination is not considered probable, the Company has set up the amount owed as a note payable. As of June 30, 2024, the Company has accrued $99,180 in interest expense related to this note payable.

Class A Ordinary Shares Subject to Possible Redemption	6 Months Ended
Class A Ordinary Shares Subject to Possible Redemption	Jun. 30, 2024
Temporary Equity Disclosure [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	Note 8—Class A O rdinary Shares Subject to Possible Redemption Class A Ordinary Shares— The Company is authorized to issue 400,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of June 30, 2024 and December 31, 2023, there were 8,624,999 Class A ordinary shares issued or outstanding (excluding 9,385,685 and 11,545,295 shares subject to possible redemption). On March 14, 2023 at the First Extraordinary General Meeting, holders of Public Shares were afforded the opportunity to require the Company to redeem their Public Shares for their pro rate share of the Trust Account. 15,494,333 out of 34,500,000 Public Shares were redeemed at a redemption price of approximately $10.43 per share, leaving 19,005,667 Public Shares remaining outstanding. On December 5, 2023, at the Second Extraordinary General Meeting, holders of Public Shares were afforded the opportunity to require the Company to redeem their Public Shares for their pro rata share of the Trust Account. At the Second Extraordinary General Meeting, 7,460,372 out of 19,005,667 Public Shares were redeemed at a redemption price of $11.00 which left 11,545,295 shares outstanding. On May 21, 2024, at the Third Extraordinary General Meeting, holders of Public Shares were afforded the opportunity to require the Company to redeem their public Shares for their pro rata share of the Trust Account. At the Third Extraordinary General Meeting, 2,159,610 out of 11,545,295 Public Shares were redeemed at a redemption price of $11.32 which left 9,385,685 shares outstanding.

Shareholders' Deficit	6 Months Ended
Shareholders' Deficit	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Shareholders' Deficit	Note 9—Shareholders’ Deficit Preference Shares —The Company is authorized to issue 1,000,000 preference shares, with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2024 and December 31, 2023, there were no preference shares issued or outstanding. Class B Ordinary Shares —The Company is authorized to issue 40,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of June 30, 2024 and December 31, 2023, there was one Class B ordinary share issued and outstanding. Holders of Ordinary Shares will vote together as a single class on all matters submitted to a vote of shareholders except as required by law. On December 22, 2023, and effected on January 2, 2024, the Sponsor and certain directors and officers of the Company voluntarily elected to convert an aggregate 8,624,999 Class B ordinary shares to Class A ordinary shares, par value $0.0001 per share, of the Company, on a one-for-one basis in accordance with the Articles. Following this conversion, there was one Class B ordinary share outstanding. All of the terms and conditions applicable to the Class B ordinary shares set forth in the letter agreement, dated December 14, 2021 and as amended on April 25, 2023 and December 11, 2023, by and among the Company, its officers, its directors and the Sponsor (the “Letter Agreement”), shall continue to apply to the Class A ordinary shares into which the Class B ordinary shares converted, including the voting agreement, transfer restrictions and waiver of any right, title, interest or claim of any kind to the Trust Account (as defined in the Letter Agreement) or any monies or other assets held therein.

Warrant Liabilities

6 Months Ended

Jun. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Warrant Liabilities

Note 10—Warrant Liabilities

Redemption of warrants when the price per Class

ordinary share equals or exceeds $18.00.

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

•

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a

30-trading

day period ending

three trading days

before the Company sends the notice of redemption to the warrant holders.

Redemption of warrants when the price per Class

A ordinary share equals or exceeds $10.00.

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

•

in whole and not in part;

•

at a price of $0.10 per warrant;

•

sub-divisions,

share dividends, reorganizations, recapitalizations and the like); and

•

if the Reference Value is less than $18.00 per share (as adjusted for share

sub-divisions,

non-redeemable

815-40.

Commitments & Contingencies	6 Months Ended
Commitments & Contingencies	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	Note 11—Commitments & Contingencies Registration Rights The holders of the Founder Shares and Private Placement Warrants (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights and shareholder agreement to be signed prior to or on the Effective Date of the IPO, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were granted the option to purchase up to 4,500,000 additional Units at the IPO price of $10.00 within 45 days of the consummation of the IPO. The underwriters fully exercised this option at the time of the IPO. The underwriters earned a cash underwriting discount of $0.20 per Unit, or $6,900,000 in the aggregate, which was paid upon the closing of the IPO. In addition, the underwriters will be entitled to a deferred fee of $0.35 per Unit, or $12,075,000 in the aggregate, with each entitled to $6,037,500. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On June 10, 2024, one of the Company’s underwriters resigned and provided a waiver of expenses and fees. Accordingly, the Company reversed the $6,037,500 liability, which represented their portion of the full $12,075,000. Legal Fees The Company had an agreement in place whereby if its legal counsel assists in the Business Combination efforts and the Business Combination is successful, it could receive up to $893,755 (the “Success Fee”). The Success Fee would only become due and payable in the event of a successful Business Combination. In accordance with ASC 805, Business Combinations, this fee was not going to be recorded until such time as a Business Combination is consummated. On May 3, 2024, the Company renegotiated its fees, inclusive of all unbilled fees incurred through April 30, 2024 as well as the Success Fee, with its legal counsel. As a result of such negotiation, the Company negotiated a fee of $7.8 million for all incurred services and agreements prior to that date with an additional $1.8 million deferred to the closing of a successful Business Combination. The $7.8 million in renegotiated fees was paid to the legal advisor from the Divestiture Escrow account and as such it is a loan included in the Note Payable to Target account on the balance sheet (see Note 7). The Company retained the $1.8 million fee on its balance sheet in Accounts payable and accrued expenses as the fee is for time and services already incurred by the legal advisor. Further, as a result of this renegotiation, the Company recognized a gain related to the renegotiation of legal fees in the amount of $2.5 million in the statement of operations. From the date of the agreement forward, the legal advisor will continue to accrue fees at their previously agreed upon rate. Consulting Agreements In April 2023, the Company entered into two agreements with each of the IPO underwriters, each to act as a capital markets advisor and as a placement agent in relation to the Business Combination. On June 9, 2023, the Company terminated the two engagement letters with one of the IPO underwriters, and such termination nullified the Company’s obligation to pay any fees under such agreements. With respect to the other IPO underwriter, as compensation for their services, half of a placement fee of 3.0% of the gross proceeds of securities sold in the placement was to be paid to the agent upon consummation of the placement (the “Placement Fee”) and $4,000,000 was to be paid to the agent upon consummation of the Business Combination (the “Transaction Fee”). The Placement Fee and the Transaction fee would only have become payable in the event the placement and the Business Combination were consummated, respectively, and as such nothing will be recorded until that time. On June 10, 2024, the other IPO underwriter resigned and waived the obligation to any fees. As such, the Placement and Transaction Fees will not become payable. In June 2023, the Company entered into an agreement with a third-party consultant to provide advisory services in relation to the Business Combination. On July 15, 2024, the Company terminated the agreement with the third-party consultant and entered into a new agreement with the third-party consultant. As a result, and as compensation for those services, an advisory fee of $3,000,000 is payable in the event the transaction is consummated (the “Advisory Fee”). This fee will only become payable in the event the Business Combination is consummated and as such nothing will be recorded until that time. Additionally, the consultant was eligible to receive a termination fee of $500,000 and to be reimbursed in the aggregate up to $500,000 in expenses in the event the Business Combination is not consummated. As part of the termination of the initial agreement, the consultant billed $1,185,488 in connection with its fees incurred. As of June 30, 2024, $1,185,488 is accrued in the Accounts Payable and Accrued Expenses line on the balance sheet.

Recurring Fair Value Measurements

6 Months Ended

Jun. 30, 2024

Fair Value Disclosures [Abstract]

Recurring Fair Value Measurements

Note 12—Recurring Fair Value Measurements


As of June 30, 2024	(Level 1)		(Level 2)		(Level 3)
Assets
Cash held in Trust Account	$	106,759,103	$	—	$	—
Liabilities
Public Warrants		1,251,000		—		—
Private Placement Warrants		—		—		1,211,000

Total	$	108,010,103	$	—	$	1,211,000


As of December 31, 2023	(Level 1)		(Level 2)		(Level 3)
Assets
Cash held in Trust Account	$	127,703,238	$	—	$	—
Liabilities
Public Warrants		3,954,000		—		—
Private Placement Warrants		—		—		3,828,000

Total	$	131,657,238	$	—	$	3,828,000

Cash held in Trust Account

During the period from March 22, 2021 (inception) through June 30, 2024, the Company did not withdraw any of the interest income from the Trust Account to pay its tax obligations.

The composition of the Company’s fair value of assets held in the Trust Account on June 30, 2024 and December 31, 2023 is as follows:


	Fair Value as of June 30, 2024	Fair Value as of December 31, 2023
Cash held in Trust Account	$106,759,103	$127,703,238

Warrant Liabilities

As of June 30, 2024, the Company’s warrant liabilities were valued at $2,462,000. Under the guidance in ASC

815-40,

re-measurement

at each balance sheet date. With each

re-measurement,

the valuations will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.

The following table presents a summary of the changes in the fair value of the Warrants liabilities classified as Level 3, measured on a recurring basis.


	Private Warrant Liability
Fair Value as of December 31, 2023	$	3,828,000
Change in fair value		(3,243,000	)

Fair Value as of March 31, 2024		584,500
Change in fair value		626,500

Fair Value as of June 30, 2024	$	1,211,000

The following table provides the significant inputs into the Monte Carlo method for the fair value of the Private Warrants:


Input	6/30/2024			12/31/2023
Share price	$	11.35		$	11.02
Exercise price	$	11.50		$	11.50
Risk-free rate of interest		4.33	%		3.84	%
Volatility		0.001	%		15.88	%
Term (in years)		5.21			5.06
Dividend yield		—	%		—	%

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 13—Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on this review, the Company did not identify any subsequent events, other than those detailed below, that would have required adjustment or disclosure in the financial statement. On August 1, 2024, Investcorp Europe Acquisition Corp I (the “Company”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that since the Company’s aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the “Notice”). The Notice additionally indicates that the Company, pursuant to the Listing Rules, has 45 calendar days, or until September 16, 2024, to submit a plan to regain compliance. If Nasdaq accepts the Company’s plan, the Company will have 180 calendar days from the date of the Notice, or until January 29, 2025, to evidence compliance. If Nasdaq were to reject the Company’s plan, Nasdaq rules permit the Company to appeal the decision to a hearings panel. On August 4, 2024, the Company entered into a Fourth Amendment to the Business Combination Agreement (the “Fourth BCA Amendment” and, the Original Business Combination Agreement, as amended by the First BCA Amendment, the Second BCA Amendment, the Third BCA Amendment and the Fourth BCA Amendment, the “Business Combination Agreement”) with Pubco, Orca and the Orca Shareholders. The Fourth BCA Amendment provides, among other things, that: (a) promptly following the execution and delivery of the Fourth BCA Amendment, Pubco, Orca Midco and the Company shall instruct the Escrow Agent to release from the Divestiture Proceeds Escrow Account to the Company (or such other person as the Company directs) an amount equal to $1,195,642.84 in connection with the settlement of certain of the Company’s Expenses (the “Additional Specified Company Transaction Expenses”), and, if the Share Contribution is consummated, such advance of the Additional Specified Company Transaction Expenses shall be treated as a partial payment by Orca Midco of Pubco’s obligation to bear the Company’s Expenses in accordance with the terms of the Business Combination Agreement; (b) the right to terminate the Business Combination Agreement that may be exercised by the Company if the Special Committee has made an Intervening Event Recommendation Change due to (i) the inability of the Company to obtain the Fairness Opinion or (ii) the good faith determination by the Special Committee, after consultation with its outside legal counsel and other advisors, that the consummation of the Transactions following the Divestiture Closing is not advisable, fair to and in the best interests of the Company and the Company’s shareholders holding SPAC Class A Shares (other than Sponsor) in accordance with the Cayman Companies Act is extended to the period beginning on the Divestiture Closing and ending on and including August 30, 2024; (c) upon a termination of the Business Combination Agreement by the Company or Orca due to a governmental order that permanently prohibits the consummation of the Transactions, the Termination Amount payable to the Company shall be $30,000,000 so long as written notice of such termination is provided during the period following the Divestiture Closing and ending on and including August 30, 2024; and (d) the Termination Amount to be paid to the Company upon certain terminations of the Business Combination Agreement shall be further reduced by the amount of the Additional Specified Company Transaction Expenses plus notional interest accruing daily from the date the Additional Specified Company Transaction Expenses are advanced to the Company (or such other person as the Company directs) up to and including the date of termination of the Business Combination Agreement at a rate of 8% per annum. On August 4, 2024, concurrently with the execution of the Fourth BCA Amendment, the Company entered into (a) a loan agreement (the “Transaction Expenses Loan Agreement”) pursuant to which Orca Midco made available to the Company an interest bearing loan in the principal amount of $7,800,000 in respect of the SPAC Specified Transaction Expenses contemplated in, and advanced to the Company in connection with the execution of, the Third BCA Amendment (the “Transaction Expenses Loan”), and (b) a loan agreement (the “Additional Transaction Expenses Loan Agreement” and, together with the Transaction Expenses Loan Agreement, the “Loan Agreements”) pursuant to which Orca Midco made available to the Company an interest bearing loan in the principal amount of $1,195,642.84 in respect of the Additional Company Specified Transaction Expenses (the “Additional Transaction Expenses Loan” and, together with the Transaction Expenses Loan, the “Loans”). The Company shall pay interest on the Loans at a rate of 8% per annum. The interest on each Loan shall (i) accrue daily, (ii) compound annually on December 31 of each year and be added to the unpaid principal amount of such Loan and (iii) be payable upon the repayment date of such Loan. Each Loan shall be due and payable on the fifth anniversary of the execution of the applicable Loan Agreement.

Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Basis of Presentation

10-Q

and Article 8 of Regulation

S-X

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form

10-K

10-

K for the year ended December 31, 2023, as filed with the SEC on April 11, 2024.

Emerging Growth Company Status

non-emerging

Use of Estimates

Cash and Cash Equivalents

Cash Held in Trust Account

Concentration of Credit Risk

Offering Costs Associated with Initial Public Offering

The Company complies with the requirements of the ASC

340-10-S99-1

one-half

Net Income (Loss) Per Ordinary Share

The Company’s statements of operations include a presentation of net income (loss) per share for Ordinary Shares subject to possible redemption and applies the

two-class

method in calculating net income (loss) per share. Net income (loss) per Ordinary Share, basic and diluted, is calculated by dividing the

pro-

rata allocation of net income (loss) for each class, by the weighted average number of Class A and Class B

non-redeemable

Ordinary Shares outstanding for the period. Net income (loss) is allocated

pro-rata

between Class A redeemable and Class B

non-redeemable

The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):


	For the three months ended
	June 30, 2024						June 30, 2023
	Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares			Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares
Basic and diluted net loss per share:
Numerator:
Allocation of net loss	$	(495,554	)	$	(404,279	)	$	(2,581,299	)	$	(1,171,424	)

Denominator:
Weighted-average shares outstanding		10,572,284			8,625,000			19,005,667			8,625,000

Basic and diluted net loss per share	$	(0.05	)	$	(0.05	)	$	(0.14	)	$	(0.14	)


	For the six months ended
	June 30, 2024				June 30, 2023
	Redeemable Class A Ordinary Shares		Non- Redeemable Ordinary Shares		Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares
Basic and diluted net (loss) income per share:
Numerator:
Allocation of net (loss) income	$	2,054,411	$	1,602,281	$	(4,355,797	)	$	(1,513,237	)

Denominator:
Weighted-average shares outstanding		11,058,789		8,625,000		24,826,742			8,625,000

Basic and diluted net (loss) income per share	$	0.19	$	0.19	$	(0.18	)	$	(0.18	)

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Fair Value Measurements

Level 3—Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

Derivative Financial Instruments

then re-valued at

or non-current based

on whether or

not net-cash settlement

or conversion of the instrument could be required within 12 months of the balance sheet date.

to re-measurement at

as non-current liabilities

as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Ordinary Shares Subject to Possible Redemption

additional paid-in capital

and accumulated deficit.

As of June 30, 2024 and December 31, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:


	June 30, 2024			December 31, 2023
As of beginning of the period	$	127,765,944		$	356,976,644
Less:
Redemptions as a result of Extraordinary General Meeting		(24,442,454	)		(243,649,972	)
Plus:
Extension Contribution		750,000			3,300,000
Remeasurement of carrying value to redemption value		2,685,613			11,139,272

Class A ordinary shares subject to possible redemption	$	106,759,103		$	127,765,944

Income taxes

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU

No. 2020-06,

“Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU

2020-06”).

The update simplifies the accounting for convertible instruments by removing certain separation models in Subtopic

470-20,

Debt—Debt with Conversion and Other Options for convertible instruments and introducing other changes. As a result of ASU

No. 2020-06,

No. 2020-06

upon its inception. The impact to the balance sheet, statements of operations and cash flows was not material.

In December 2023, the FASB issued ASU No

2023-09,

“Income Taxes (Topic 740)—Improvements to Income Tax Disclosures” (“ASU

2023-09”)

2023-09

on its financial position, results of operations or financial statement disclosure.

Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Summary of Basic and Diluted Net Income Per Ordinary Share

The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):


	For the three months ended
	June 30, 2024						June 30, 2023
	Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares			Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares
Basic and diluted net loss per share:
Numerator:
Allocation of net loss	$	(495,554	)	$	(404,279	)	$	(2,581,299	)	$	(1,171,424	)

Denominator:
Weighted-average shares outstanding		10,572,284			8,625,000			19,005,667			8,625,000

Basic and diluted net loss per share	$	(0.05	)	$	(0.05	)	$	(0.14	)	$	(0.14	)


	For the six months ended
	June 30, 2024				June 30, 2023
	Redeemable Class A Ordinary Shares		Non- Redeemable Ordinary Shares		Redeemable Class A Ordinary Shares			Non- Redeemable Ordinary Shares
Basic and diluted net (loss) income per share:
Numerator:
Allocation of net (loss) income	$	2,054,411	$	1,602,281	$	(4,355,797	)	$	(1,513,237	)

Denominator:
Weighted-average shares outstanding		11,058,789		8,625,000		24,826,742			8,625,000

Basic and diluted net (loss) income per share	$	0.19	$	0.19	$	(0.18	)	$	(0.18	)

Summary of Class A Ordinary Shares Subject to Possible Redemption

As of June 30, 2024 and December 31, 2023, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:


	June 30, 2024			December 31, 2023
As of beginning of the period	$	127,765,944		$	356,976,644
Less:
Redemptions as a result of Extraordinary General Meeting		(24,442,454	)		(243,649,972	)
Plus:
Extension Contribution		750,000			3,300,000
Remeasurement of carrying value to redemption value		2,685,613			11,139,272

Class A ordinary shares subject to possible redemption	$	106,759,103		$	127,765,944

Recurring Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2024

Fair Value Disclosures [Abstract]

Summary of Fair Value Assets and Liabilities


As of June 30, 2024	(Level 1)		(Level 2)		(Level 3)
Assets
Cash held in Trust Account	$	106,759,103	$	—	$	—
Liabilities
Public Warrants		1,251,000		—		—
Private Placement Warrants		—		—		1,211,000

Total	$	108,010,103	$	—	$	1,211,000


As of December 31, 2023	(Level 1)		(Level 2)		(Level 3)
Assets
Cash held in Trust Account	$	127,703,238	$	—	$	—
Liabilities
Public Warrants		3,954,000		—		—
Private Placement Warrants		—		—		3,828,000

Total	$	131,657,238	$	—	$	3,828,000

Summary of Fair Value of Held To Maturity Securities

The composition of the Company’s fair value of assets held in the Trust Account on June 30, 2024 and December 31, 2023 is as follows:


	Fair Value as of June 30, 2024	Fair Value as of December 31, 2023
Cash held in Trust Account	$106,759,103	$127,703,238

Summary of Fair Value of Warrants Liabilities

The following table presents a summary of the changes in the fair value of the Warrants liabilities classified as Level 3, measured on a recurring basis.


	Private Warrant Liability
Fair Value as of December 31, 2023	$	3,828,000
Change in fair value		(3,243,000	)

Fair Value as of March 31, 2024		584,500
Change in fair value		626,500

Fair Value as of June 30, 2024	$	1,211,000

Summary of Fair Value Measurement Inputs and Valuation Techniques

The following table provides the significant inputs into the Monte Carlo method for the fair value of the Private Warrants:


Input	6/30/2024			12/31/2023
Share price	$	11.35		$	11.02
Exercise price	$	11.50		$	11.50
Risk-free rate of interest		4.33	%		3.84	%
Volatility		0.001	%		15.88	%
Term (in years)		5.21			5.06
Dividend yield		—	%		—	%

Organization and Business Operation - Additional Information (Detail) - USD ($)					6 Months Ended		18 Months Ended
	May 21, 2024	Dec. 05, 2023	Mar. 14, 2023	Dec. 17, 2021	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 17, 2024	Jun. 06, 2024	Apr. 15, 2024	Dec. 31, 2023	Dec. 22, 2023	Nov. 27, 2023	Nov. 15, 2023	Jul. 06, 2023	Mar. 07, 2023	Feb. 22, 2023
Organization And Plan Of Operation [Line Items]
Entity Incorporation, Date of Incorporation					Mar. 22, 2021
Restricted investments term				185 days
Due from Banks					$ 182,038		$ 182,038
Working capital (deficit)					18,324,540		18,324,540
Proceeds from Issuance of Common Stock				$ 25,000
Proceeds from unsecured and non-interest bearing promissory note				$ 300,000
Working capital loans					6,450,000		6,450,000				$ 4,750,000
Percentage of public shares aggregate to redeeming restriction				15.00%
Assets held-in-trust			$ 198,200,000		106,759,103		106,759,103				$ 127,703,238
Net Tangible Asset			5,000,001
Percentage of outstanding shares																	79.10%
Extension Contribution					750,000	$ 1,400,000	$ 4,050,000
Interest Income [Member]
Organization And Plan Of Operation [Line Items]
Interest receivable on investments held in trust account					6,975,116
Sponsor [Member]
Organization And Plan Of Operation [Line Items]
Contribution to trust account made by the sponsor			$ 350,000
Share price			$ 0.03
Sponsor [Member] \| Extension Amendment Proposal Nine [Member]
Organization And Plan Of Operation [Line Items]
Extension Contribution					350,000
Sponsor [Member] \| Extension Amendment Proposal Six [Member]
Organization And Plan Of Operation [Line Items]
Extension Contribution					$ 150,000
Sponsor [Member] \| Convertible Unsecured Loan [Member]
Organization And Plan Of Operation [Line Items]
Debt Instrument Face Amount									$ 1,200,000	$ 750,000			$ 1,250,000	$ 500,000	$ 1,700,000	$ 2,000,000
Debt instrument conversion price																$ 1
Sponsor [Member] \| Private Placement Warrants [Member]
Organization And Plan Of Operation [Line Items]
Class of warrants and rights issued during the period				16,700,000
Class of warrants and rights issued price per warrant				$ 1
Proceeds from Issuance of Private Placement				$ 16,700,000
Common Class A [Member]
Organization And Plan Of Operation [Line Items]
Temporary Equity Shares Outstanding	11,545,295	19,005,667	34,500,000		9,385,685		9,385,685				11,545,295
Temproary equity redemption price, per share	$ 11.32	$ 11	$ 10.43		$ 11.37		$ 11.37				$ 11.07
Common stock Shares Outstanding		11,545,295	19,005,667		8,624,999		8,624,999				8,624,999	8,624,999
Assets held-in-trust	$ 9,385,685
Cash Withdrawn from Trust Account for Redemption Of Temporary Equity			$ 161,600,000
Common Class A [Member] \| Extension Amendment Proposal [Member]
Organization And Plan Of Operation [Line Items]
Temporary Equity Shares Outstanding			15,494,333
Common Class A [Member] \| Extension Amendment Proposal Two [Member]
Organization And Plan Of Operation [Line Items]
Temporary Equity Shares Outstanding		7,460,372
Temproary equity redemption price, per share		$ 11
Common stock Shares Outstanding		11,545,295
Cash Withdrawn from Trust Account for Redemption Of Temporary Equity		$ 82,000,000
Common Class A [Member] \| Extension Amendment Proposal Three [Member]
Organization And Plan Of Operation [Line Items]
Temporary Equity Shares Outstanding	2,159,610
Temproary equity redemption price, per share	$ 11.32
Cash Withdrawn from Trust Account for Redemption Of Temporary Equity	$ 24,400,000
Common Class A [Member] \| Sponsor [Member]
Organization And Plan Of Operation [Line Items]
Commitment to contribute to trust account								$ 150,000
Commitment to contribute to trust account per share								0.02
Common Class A [Member] \| IPO [Member]
Organization And Plan Of Operation [Line Items]
Stock shares issued during the period shares				34,500,000
Shares Issued, Price Per Share				$ 10
Proceeds from Issuance Initial Public Offering				$ 345,000,000
Per share value of restricted investments				$ 10.2	$ 10.2
Common Class A [Member] \| IPO [Member] \| Maximum [Member]
Organization And Plan Of Operation [Line Items]
Initial investment held in the trust account				$ 351,900,000
Common Class A [Member] \| Over-Allotment Option [Member]
Organization And Plan Of Operation [Line Items]
Stock shares issued during the period shares				4,500,000
Common Class A and B [Member]
Organization And Plan Of Operation [Line Items]
Common stock Shares Outstanding																	34,372,929

Significant Accounting Policies - Additional Information (Detail) - USD ($)		6 Months Ended
	Dec. 17, 2021	Jun. 30, 2024	Dec. 31, 2023	Mar. 14, 2023
Cash		$ 182,038	$ 98,676
Cash Equivalents		0	0
Cash, FDIC Insured Amount		250,000
Accumulated deficit		(26,824,903)	(33,083,482)
Marketable securities held in Trust Account		106,759,103	$ 127,703,238	$ 198,200,000
Accrued for interest and penalties		$ 0
Effective Income Tax Rate Reconciliation, Percent		50.00%
Unrecognized Tax Benefits		$ 0
Class of warrant or right, outstanding		33,950,000
Other Offering Cost Adjustments	$ 94,443
Private Placement Warrants [Member]
Class of warrant or right, outstanding		16,700,000
Public Warrants [Member]
Class of warrant or right, outstanding		17,250,000
IPO And Private Placement [Member] \| Warrant [Member]
Offering costs	20,078,227
Underwriting fee	6,900,000
Accumulated deficit	854,057
Deferred underwriting fee	12,075,000
Other offering costs	$ 1,103,227

Significant Accounting Policies - Summary of Basic and Diluted Net Income Per Ordinary Share (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Redeemable Class A ordinary shares [Member]
Numerator:
Allocation of net (loss) income	$ (495,554)	$ (2,581,299)	$ 2,054,411	$ (4,355,797)
Denominator:
Weighted-average shares outstanding, Basic	10,572,284	19,005,667	11,058,789	24,826,742
Weighted-average shares outstanding, Diluted	10,572,284	19,005,667	11,058,789	24,826,742
Basic net (loss) income per share	$ (0.05)	$ (0.14)	$ 0.19	$ (0.18)
Diluted net (loss) income per share	$ (0.05)	$ (0.14)	$ 0.19	$ (0.18)
Non-Redeemable ordinary shares [Member]
Numerator:
Allocation of net (loss) income	$ (404,279)	$ (1,171,424)	$ 1,602,281	$ (1,513,237)
Denominator:
Weighted-average shares outstanding, Basic	8,625,000	8,625,000	8,625,000	8,625,000
Weighted-average shares outstanding, Diluted	8,625,000	8,625,000	8,625,000	8,625,000
Basic net (loss) income per share	$ (0.05)	$ (0.14)	$ 0.19	$ (0.18)
Diluted net (loss) income per share	$ (0.05)	$ (0.14)	$ 0.19	$ (0.18)

Significant Accounting Policies - Summary of Class A Ordinary Shares Subject to Possible Redemption (Detail) - USD ($)	6 Months Ended		12 Months Ended	18 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Jun. 30, 2024
Plus:
Extension Contribution	$ 750,000	$ 1,400,000		$ 4,050,000
Class A ordinary shares subject to possible redemption [Member]
As of beginning of the period	127,765,944	$ 356,976,644	$ 356,976,644	356,976,644
Less:
Redemptions as a result of Extraordinary General Meeting	(24,442,454)		(243,649,972)
Plus:
Extension Contribution	750,000		3,300,000
Remeasurement of carrying value to redemption value	2,685,613		11,139,272
Class A ordinary shares subject to possible redemption	$ 106,759,103		$ 127,765,944	$ 106,759,103

Initial Public Offering - Additional Information (Detail) - USD ($)		6 Months Ended
	Dec. 17, 2021	Jun. 30, 2024	Dec. 31, 2023
Initial Public Offering [Line Items]
Accumulated deficit		$ (26,824,903)	$ (33,083,482)
IPO And Private Placement [Member] \| Warrant [Member]
Initial Public Offering [Line Items]
Additional Paid-in Capital	$ 19,224,170
Offering costs	20,078,227
Underwriting fee	6,900,000
Deferred underwriting fee	12,075,000
Other offering costs	1,103,227
Accumulated deficit	$ 854,057
Common Class A [Member] \| IPO [Member]
Initial Public Offering [Line Items]
Stock shares issued during the period shares	34,500,000
Shares Issued, Price Per Share	$ 10
Proceeds from Issuance Initial Public Offering	$ 345,000,000
Per share value of restricted investments	$ 10.2	$ 10.2
Common Class A [Member] \| IPO [Member] \| Maximum [Member]
Initial Public Offering [Line Items]
Payment to acquire restricted investments	$ 351,900,000
Common Class A [Member] \| Over-Allotment Option [Member]
Initial Public Offering [Line Items]
Stock shares issued during the period shares	4,500,000
Public Warrants [Member] \| Common Class A [Member]
Initial Public Offering [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 11.5

Signed Business Combination Agreement - Additional information (Detail)					6 Months Ended
	May 07, 2024 USD ($)	May 03, 2024 USD ($)	Dec. 15, 2023 USD ($) $ / shares shares	Apr. 25, 2023 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) shares	Dec. 14, 2023	Mar. 14, 2023 $ / shares
Business Acquisition [Line Items]
Cash receivable upon business combination transaction				$ 10,000,000
Number of trading days for determining the share price				20 days
Number of consecutive trading days for determining the share price				30 days
Class of warrant or right, outstanding \| shares					33,950,000
Delivery Of Supplement To Disclosure Schedule					14 days
Increase Decrease Of Adjustment On Value Of The Enterprise					$ 16,000,000
Proportion Of Encashment Of Options						10
Amount Payable Of Termination Due To Breach Of Agreement		$ 30,000,000			30,000,000
Amount Payable Of Termination Due To Non Farness Opinion					30,000,000
Proceeds From Escrow Deposit		$ 7,800,000
Rate Of Amount Payable Of Termination		8.00%
OPSEC Holdings [Member] \| Unsecured Convertible Debt [Member]
Business Acquisition [Line Items]
Debt Conversion, Converted Instrument, Shares Issued \| shares			5,000,000
Debt Conversion Converted Instrument Price Per Share \| $ / shares			$ 1
Debt Conversion, Converted Instrument, Amount			$ 5,000,000
PUBCO [Member]
Business Acquisition [Line Items]
Conversion of Stock, Shares Converted \| shares			526,316
Common Stock, Par or Stated Value Per Share \| $ / shares			$ 0.0001
Promissory Note [Member]
Business Acquisition [Line Items]
Debt Instrument, Face Amount					73,800,000
Sponsor [Member]
Business Acquisition [Line Items]
Share price \| $ / shares							$ 0.03
Increase Decrease Of Adjustment On Value Of The Enterprise					160,000,000
Orca Midco [Member]
Business Acquisition [Line Items]
Proceeds from sale and collection of notes receivable	$ 73,800,000
First Distribution [Member]
Business Acquisition [Line Items]
Payment for Contingent Consideration Liability, Operating Activities		$ 3,000,000
Second Distribution [Member]
Business Acquisition [Line Items]
Payment for Contingent Consideration Liability, Operating Activities		$ 73,800,000
Termination Due To Post Divestiture Termination Period [Member]
Business Acquisition [Line Items]
Amount Payable Of Termination Due To Failue					30,000,000
Amount Payable Of Termination Due To Government Order					30,000,000
Termination Due To Other Causes [Member]
Business Acquisition [Line Items]
Amount Payable Of Termination Due To Failue					25,000,000
Amount Payable Of Termination Due To Government Order					$ 25,000,000
Pubco Ordinary Shares [Member]
Business Acquisition [Line Items]
Shares issued \| shares				23,577,550
Additional shares issued \| shares				1,277,550
Share price \| $ / shares				$ 12
Business Combination Agreement [Member]
Business Acquisition [Line Items]
Cash receivable upon business combination transaction				$ 10,000,000
Sponsor Support Agreement [Member]
Business Acquisition [Line Items]
Percentage of shares held by subsidiary				50.00%
Maximum amount payable to purchase private placement securities				$ 50,000,000
Common Stock				$ 0
Common Stock, Shares, Outstanding \| shares				2,555,100
Class of warrant or right, outstanding \| shares				2,050,000
Expenses Reimbursable				$ 20,000,000

Private Placement Warrants - Additional Information (Detail) - Private Placement [Member]	6 Months Ended
	Jun. 30, 2024 USD ($) $ / shares shares
Common Class A [Member]
Private Placement Warrants [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 11.5
Sponsor [Member]
Private Placement Warrants [Line Items]
Class of warrants and rights issued during the period \| shares	16,700,000
Class of warrants and rights issued price per warrant	$ 1
Proceeds from Issuance of Private Placement \| $	$ 16,700,000

Related Party Transactions - Additional Information (Detail) - USD ($)					6 Months Ended
	Dec. 22, 2023	Dec. 14, 2021	Nov. 03, 2021	Apr. 01, 2021	Jun. 30, 2024	Jun. 06, 2024	Apr. 15, 2024	Dec. 31, 2023	Dec. 05, 2023	Nov. 27, 2023	Nov. 15, 2023	Jul. 06, 2023	Mar. 14, 2023	Mar. 07, 2023
Related Party Transaction [Line Items]
Stock issued during period value shares for services		8,625,000
Threshold consecutive trading days					30 days
Utilization Of Loan Towards Contribution					$ 4,050,000
Percentage Of Increase In Founder Shares		20.00%
Unsecured Debt [Member]
Related Party Transaction [Line Items]
Unsecured loan, principal amount						$ 1,200,000	$ 750,000			$ 1,250,000	$ 500,000	$ 1,700,000
Working Capital Loans [Member]
Related Party Transaction [Line Items]
Outstanding loans					$ 6,450,000
Sponsor and Directors and Executive Officers [Member]
Related Party Transaction [Line Items]
Restrictions on transfer period of time after business combination completion					1 year
Share price					$ 12
Threshold trading days					20 days
Threshold consecutive trading days					30 days
Threshold Period After Business Combination in Which Specified Trading Days Within Any Specified Trading Day Period Commences					120 days
Sponsor [Member]
Related Party Transaction [Line Items]
Share price													$ 0.03
Sponsor [Member] \| Convertible Unsecured Loan [Member]
Related Party Transaction [Line Items]
Debt instrument face value						$ 1,200,000	$ 750,000			$ 1,250,000	$ 500,000	$ 1,700,000		$ 2,000,000
Debt instrument conversion price per share														$ 1
Sponsor [Member] \| Working Capital Loans [Member]
Related Party Transaction [Line Items]
Working capital loans convertible into warrants					$ 2,000,000
Debt instrument conversion price per share					$ 1
Common Class A [Member]
Related Party Transaction [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.0001				$ 0.0001			$ 0.0001
Common Stock, Shares, Outstanding	8,624,999				8,624,999			8,624,999	11,545,295				19,005,667
Common Class B [Member]
Related Party Transaction [Line Items]
Stock issued during period value shares for services				8,625,000
Stock issued during period value issued for services				$ 25,000
Conversion of Stock, Shares Converted	8,624,999
Common Stock, Par or Stated Value Per Share					$ 0.0001			$ 0.0001
Common Stock, Shares, Outstanding	1				1			1
Common Class B [Member] \| Transfer of Founder Shares [Member]
Related Party Transaction [Line Items]
Sale of stock price per share			$ 0.12
Common stock excess fair value of shares issued over the nominal purchase price			$ 5,292,600
Common Class B [Member] \| Baroness Ruby McGregor Smith [Member] \| Transfer of Founder Shares [Member]
Related Party Transaction [Line Items]
Founder shares transferred during period			718,750
Common Class B [Member] \| Peter McKellar [Member] \| Transfer of Founder Shares [Member]
Related Party Transaction [Line Items]
Founder shares transferred during period			479,167
Common Class B [Member] \| Pam Jackson [Member] \| Transfer of Founder Shares [Member]
Related Party Transaction [Line Items]
Founder shares transferred during period			30,000
Common Class B [Member] \| Laurence Ponchaut [Member] \| Transfer of Founder Shares [Member]
Related Party Transaction [Line Items]
Founder shares transferred during period			30,000
Common Class B [Member] \| Adah Almutairi [Member] \| Transfer of Founder Shares [Member]
Related Party Transaction [Line Items]
Founder shares transferred during period			30,000

Loan Payable to Target - Additional Information (Detail) - USD ($)		3 Months Ended		6 Months Ended
	May 03, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Payables and Accruals [Abstract]
Legal fees	$ 7,800,000			$ 7,800,000
Interest rate	8.00%
Interest expense		$ 99,180	$ 0	$ 99,180	$ 0

Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail) - USD ($)				6 Months Ended
	May 21, 2024	Dec. 05, 2023	Mar. 14, 2023	Jun. 30, 2024	Dec. 31, 2023	Dec. 22, 2023
Temporary Equity [Line Items]
Assets held-in-trust			$ 198,200,000	$ 106,759,103	$ 127,703,238
Common Class A [Member]
Temporary Equity [Line Items]
Common Stock, Shares Authorized				400,000,000	400,000,000
Common Stock, Shares, Issued				8,624,999	8,624,999
Common Stock, Shares, Outstanding		11,545,295	19,005,667	8,624,999	8,624,999	8,624,999
Common Stock, Par or Stated Value Per Share				$ 0.0001	$ 0.0001	$ 0.0001
Common stock, Voting Rights				one
Temporary Equity, Shares Outstanding	11,545,295	19,005,667	34,500,000	9,385,685	11,545,295
Stock issued during period, stock options exercised	2,159,610	7,460,372	15,494,333
Temporary Equity, Redemption Price Per Share	$ 11.32	$ 11	$ 10.43	$ 11.37	$ 11.07
Assets held-in-trust	$ 9,385,685

Shareholders' Deficit - Additional Information (Detail) - $ / shares		6 Months Ended
	Dec. 22, 2023	Jun. 30, 2024	Dec. 31, 2023	Dec. 05, 2023	Mar. 14, 2023
Class of Stock [Line Items]
Preferred Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized		1,000,000	1,000,000
Preferred Stock, Shares Issued		0	0
Preferred Stock, Shares Outstanding		0	0
Stock conversion basis on consummation of the initial business combination		one-for-one
Common Class A [Member]
Class of Stock [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized		400,000,000	400,000,000
Common Stock ,Shares Issued		8,624,999	8,624,999
Common stock, Shares Outstanding	8,624,999	8,624,999	8,624,999	11,545,295	19,005,667
Common Class B [Member]
Class of Stock [Line Items]
Common Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Common Stock, Shares Authorized		40,000,000	40,000,000
Common Stock ,Shares Issued		1	1
Common stock, Shares Outstanding	1	1	1
Conversion of Stock, Shares Converted	8,624,999

Warrant Liabilities - Additional Information (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2024	Dec. 17, 2021
Class of Warrant or Right [Line Items]
Threshold consecutive trading days	30 days
Adjustment of exercise price of warrants based on market value and newly issued price	115.00%
Class of warrant or right, outstanding	33,950,000
Common Class A [Member]
Class of Warrant or Right [Line Items]
Percentage of consideration receivable in successor entity equity		70.00%
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Period to exercise warrants after business combination	30 days
Period to file registration statement after Business Combination	20 days
Period for registration statement to become effective	60 days
Percentage of gross proceeds on total equity proceeds	60.00%
Threshold trading days determining volume weighted average price	20 days
Class of warrant or right, outstanding	17,250,000
Public Warrants [Member] \| Common Class A [Member]
Class of Warrant or Right [Line Items]
Threshold issue price per share	$ 9.2
Public Warrants [Member] \| Exceeds $18.00 [Member]
Class of Warrant or Right [Line Items]
Warrant redemption price	$ 0.01
Minimum notice period for redemption of warrants	30 days
Share price	$ 18
Threshold trading days	20 days
Threshold number of business days before sending notice of redemption to warrant holders	3 days
Stock price trigger for redemption of public warrants	$ 18
Adjustment of redemption price of stock based on market value and newly issued price	180
Public Warrants [Member] \| Exceeds $10.00 [Member]
Class of Warrant or Right [Line Items]
Warrant redemption price	$ 0.1
Minimum notice period for redemption of warrants	30 days
Share price	$ 10
Stock price trigger for redemption of public warrants	10
Adjustment of redemption price of stock based on market value and newly issued price	$ 100
Private Placement Warrants [Member]
Class of Warrant or Right [Line Items]
Period to exercise warrants after business combination	30 days
Class of warrant or right, outstanding	16,700,000

Commitments & Contingencies - Additional Information (Detail) - USD ($)						1 Months Ended	3 Months Ended		6 Months Ended
	Jul. 15, 2024	Jun. 10, 2024	May 03, 2024	Jun. 09, 2023	Dec. 17, 2021	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Other Commitments [Line Items]
Business Combination Legal Success Fee Payable							$ 893,755		$ 893,755
Deferred Fee Payable		$ 6,037,500					6,037,500		6,037,500
Legal Fees Payable			$ 7,800,000
Deferred Legal Fee Payable			1,800,000				1,800,000		1,800,000
Legal Fees			$ 7,800,000						7,800,000
Forgiveness of legal fees							$ 2,546,926	$ 0	2,546,926	$ 0
Underwriting Agreement [Member]
Other Commitments [Line Items]
Transaction Fees for business consummation				$ 4,000,000
Underwriting Agreement [Member] \| Over-Allotment Option [Member]
Other Commitments [Line Items]
Common stock shares subscribed but unissued					4,500,000
Shares Issued, Price Per Share					$ 10
Term of option for underwriters to purchase additional Units to cover over-allotments					45 days
Cash underwriting discount per unit					$ 0.2
Payment of cash underwriting discount					$ 6,900,000
Deferred underwriting discount per unit					$ 0.35
Underwriting discount incurred but not paid		$ 12,075,000			$ 12,075,000
Consulting Agreements [Member]
Other Commitments [Line Items]
Percentage of gross proceeds of securities sold to pay placement fee to agent				3.00%
Advisory fee in relation to business combination	$ 3,000,000
Actual expenses incurred by the agent and consultant									$ 1,185,488
Consulting Agreements [Member] \| Business Combination Not Consummated [Member]
Other Commitments [Line Items]
Termination Fee						$ 500,000
Consulting Agreements [Member] \| Business Combination Consummated [Member]
Other Commitments [Line Items]
Maximum reimbursement of expenses						$ 500,000

Recurring Fair Value Measurements - Summary of Fair Value Assets and Liabilities (Detail) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Liabilities
Derivative Liability	$ 2,462,000
Recurring [Member] \| Level 1 [Member]
Assets
Cash held in Trust Account	106,759,103	$ 127,703,238
Liabilities
Total	108,010,103	131,657,238
Recurring [Member] \| Level 1 [Member] \| Public Warrants [Member]
Liabilities
Derivative Liability	$ 1,251,000	$ 3,954,000
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Derivative Liability, Noncurrent	Derivative Liability, Noncurrent
Recurring [Member] \| Level 1 [Member] \| Private Placement Warrants [Member]
Liabilities
Derivative Liability	$ 0	$ 0
Recurring [Member] \| Level 2 [Member]
Assets
Cash held in Trust Account	0	0
Liabilities
Total	0	0
Recurring [Member] \| Level 2 [Member] \| Public Warrants [Member]
Liabilities
Derivative Liability	$ 0	$ 0
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Derivative Liability, Noncurrent	Derivative Liability, Noncurrent
Recurring [Member] \| Level 2 [Member] \| Private Placement Warrants [Member]
Liabilities
Derivative Liability	$ 0	$ 0
Recurring [Member] \| Level 3 [Member]
Assets
Cash held in Trust Account	0	0
Liabilities
Total	1,211,000	3,828,000
Recurring [Member] \| Level 3 [Member] \| Public Warrants [Member]
Liabilities
Derivative Liability	$ 0	$ 0
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Derivative Liability, Noncurrent	Derivative Liability, Noncurrent
Recurring [Member] \| Level 3 [Member] \| Private Placement Warrants [Member]
Liabilities
Derivative Liability	$ 1,211,000	$ 3,828,000

Recurring Fair Value Measurements - Summary of Fair Value of Held To Maturity Securities (Detail) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Cash [Member]
Schedule of Held-to-maturity Securities [Line Items]
Cash held in Trust Account	$ 106,759,103	$ 127,703,238

Recurring Fair Value Measurements - Summary of Fair Value of Warrants Liabilities (Detail) - Private Placement Warrants [Member] - USD ($)	3 Months Ended
	Jun. 30, 2024	Mar. 31, 2024
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value beginning balance	$ 584,500	$ 3,828,000
Change in fair value	$ 626,500	$ (3,243,000)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Fair Value Adjustment of Warrants	Fair Value Adjustment of Warrants
Fair value ending balance	$ 1,211,000	$ 584,500

Recurring Fair Value Measurements - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) - Level 3 [Member]	Jun. 30, 2024 yr	Dec. 31, 2023 yr
Share price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement inputs	11.35	11.02
Exercise price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement inputs	11.5	11.5
Risk-free rate of interest [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement inputs	4.33	3.84
Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement inputs	0.001	15.88
Term (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement inputs	5.21	5.06
Dividend yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement inputs	0	0

Recurring Fair Value Measurements - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2024 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Warrant liabilities	$ 2,462,000
FairValue Derivative Asset Liability Measured On Recurring , Transfers Net	$ 0

Subsequent Events - Additional Information (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2024	Aug. 04, 2024	Aug. 01, 2024	May 03, 2024
Subsequent Event [Line Items]
Amount Payable Of Termination Due To Breach Of Agreement	$ 30,000,000			$ 30,000,000
Rate of amount payable of termination				8.00%
Minimum notice period for regain compliance	45 days
Minimum notice period for evidence compliance	180 days
Subsequent Event [Member]
Subsequent Event [Line Items]
Warrants outstanding			$ 1,000,000
Subsequent Event [Member] \| Transaction Expenses Loan [Member]
Subsequent Event [Line Items]
Principal amount of loan		$ 7,800,000
Subsequent Event [Member] \| Additional Transaction Expenses Loan [Member]
Subsequent Event [Line Items]
Principal amount of loan		$ 1,195,642.84
Rate of interest per annum		8.00%